IP Verse

Sanofi Biotechnologies vs. Amgen - UPC_CFI_505/2023

The UPC Case UPC_CFI_505/2023 was filed on 10 Jan, 2024 by the plaintiff Sanofi Biotechnologies against the defendant Amgen.

Case Details

    Case Number:

    UPC_CFI_505/2023

    Patent Number:

    EP3536712

    Filing Date:

    10 Jan, 2024

    Proceeding Type:

    Infringement

    Case Phase:

    Case Closed

    Plaintiffs:

    • Sanofi Biotechnologies

    Plaintiff Representatives:

    • Niels HOELDER

    Defendants:

    • Amgen

    Defendant Representatives:

    • Johannes HESELBERGER

    Judges:

    • Andras Kupecz
    • Berenice Thom
    • Ronny Thomas
    • Xavier Dorland-Galliot

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Jun 27, 2025Receipt-
Jun 23, 2025250623 Request Re. Audio Recording-
Jun 16, 2025Workflow Closed
Jun 16, 2025Outcome Of The Order-
Jun 13, 2025Receipt-
Jun 13, 202520250613 Application Cost Decision Amgen-
May 13, 2025Headnote And Keywords-
May 13, 2025Final Decision
May 13, 2025Decisionoutcome-
Apr 30, 2025Outcome Of The Order-
Apr 30, 2025Confirmation Of Appointment
Apr 22, 2025Receipt-
Apr 17, 202520250417 Recording Of Oral Hearing Request Amgen En-
Apr 4, 2025Reschedule Announcement
Mar 3, 2025Request For Correction-
Mar 3, 2025Receipt-
Mar 3, 2025250227 Email Re Correction-
Mar 3, 2025250214 Order Correction Of Claimant'S Name-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S04-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S03-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S02-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S01-
Feb 21, 2025Summon Oral Hearing-
Feb 21, 2025Summary Of Citations-
Feb 21, 2025Response On Requests And Synoptical Table-
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure-
Feb 21, 2025Hearing Dates-
Feb 21, 2025Exhibit Bp 85 Amgen-
Feb 21, 202520250221 Table Of Exhibits And Request Ars Brief Amgen-
Feb 20, 2025Rejecting Time Extension
Feb 20, 2025Rectification Order-
Feb 20, 2025Outcome Of The Order-
Feb 20, 2025Course Of The Oral Hearing
Feb 19, 2025Written Procedure Closure-
Feb 19, 2025Template Order-
Feb 19, 2025Receipt-
Feb 19, 2025Outcome Of The Order-
Feb 19, 2025Order Interim Procedure
Feb 19, 2025Art. 33 3)(A) Upca
Feb 18, 2025Slides For The Hearing On 25 February-
Feb 18, 2025Request On Timing Of Complete Statement Of Claim-
Feb 18, 2025Receipt-
Feb 18, 2025Exhibit Bp84 Amgen-
Feb 18, 2025Cover Letter On Submssion Of Slides-
Feb 18, 202520250218 Response Amgen App 6226 2025-
Feb 18, 202520250218 Comment Re Cfr Amgen App 5925 2025 En Signed-
Feb 14, 2025Outcome Of The Order-
Feb 14, 2025Opportunity To Comment-
Feb 14, 2025Decision Regarding R.9 Request
Feb 14, 2025Correction Name
Feb 6, 2025Receipt-
Feb 5, 2025Receipt-
Feb 5, 2025He 116A-
Feb 5, 2025Application Pursuant To Rule 9.1 Rop-
Feb 5, 20253Rd Prof. Parhofer Declaration-
Feb 4, 2025Sanofi V Amgen Rule 336 Rop Request To File Demonstratives-
Feb 3, 2025Rectification
Jan 30, 2025Separation Of Proceedings
Jan 21, 2025Receipt-
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation-
Jan 20, 2025Receipt-
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action-
Dec 23, 2024R. 20.2 Rop Information
Dec 23, 2024Preliminary Objection Decisionoutcome-
Dec 13, 2024Order Set Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates-
Dec 5, 2024Panel Appointment-
Nov 29, 2024Outcome Of The Order-
Nov 29, 2024Order Inform Pcfi Allocation Tqj
Nov 14, 2024Receipt-
Nov 13, 2024Exhibit Bp83 Court Notice Re Re Scheduled Oral Hearing In Main Damages Case-
Nov 13, 2024Exhibit Bp82 Minutes Oral Hearing In Main Damages Case-
Nov 13, 2024Application To Comment Re. Scheduling Nov 13-
Nov 11, 2024He 115 241016 Munich Court Order-
Nov 11, 2024He 114 Confirmation Ski Rauline (Redacted)-
Nov 11, 2024241111 Comments-
Nov 11, 202420241111 Request For Hearing Date Brief Of Amgen-
Nov 5, 2024Pre Order Opportunity To Comment Oral Hearing Date-
Oct 21, 2024Receipt-
Oct 18, 2024EP857Reply To Amgen Response To Application For Leave To Amend Case (Signed)-
Oct 9, 2024Response To Application For Leave To Amend The Case R263-
Oct 9, 2024Receipt-
Oct 8, 2024241008 Submission On Lis Pendens-
Oct 4, 2024Receipt-
Oct 4, 2024Correction-
Oct 3, 2024Application-
Sep 26, 2024Order Opportunity To Comment-
Sep 25, 2024Receipt-
Sep 25, 2024He 107 Confirmatory License Agreement-
Sep 25, 2024He 105 Intention To Grant-
Sep 25, 2024He 104 Decision To Grant-
Sep 25, 2024Exhibit He 109-
Sep 25, 2024Exhibit He 108-
Sep 25, 2024Exhibit He 106-
Sep 25, 2024Application To Amend Case-
Sep 23, 2024Infringement Rejoinder And Validity Reply-
Sep 23, 2024Exhibit Bp81-
Sep 23, 2024Exhibit Bp80-
Sep 23, 2024Exhibit Bp79-
Sep 23, 2024Exhibit Bp78-
Sep 23, 2024Exhibit Bp77-
Sep 23, 2024Exhibit Bp76-
Sep 23, 2024Exhibit Bp75-
Sep 23, 2024Acknowledgement Of Lodging-
Jul 22, 2024Reply To Defence And Defence To Counterclaim-
Jul 22, 2024He 99 Szarek-
Jul 22, 2024He 98 Safarova-
Jul 22, 2024He 97 Declaration Of Prof Di Angelantonio-
Jul 22, 2024He 96 Swergold Poster-
Jul 22, 2024He 95 Lagor And Millar-
Jul 22, 2024He 94 Excerpt From Clinicaltrials Gov Amg145-
Jul 22, 2024He 93 Excerpt From Clinicaltrials Gov Gauss-
Jul 22, 2024He 92 Declaration Of Prof Parhofer On Validity-
Jul 22, 2024He 91 Nct012884443-
Jul 22, 2024He 90 Repatha Fda Approval-
Jul 22, 2024He 89 Praluent Fda Approval-
Jul 22, 2024He 88 Kamstrup-
Jul 22, 2024He 87 Jama-
Jul 22, 2024He 86 Cohen-
Jul 22, 2024He 85 Romangnuolo-
Jul 22, 2024He 84 Stroes-
Jul 22, 2024He 83 Albers (Aim High)-
Jul 22, 2024He 82 Willeit-
Jul 22, 2024He 81 Sabatine-
Jul 22, 2024He 80 Schwartz-
Jul 22, 2024He 79 Ober-
Jul 22, 2024He 78 Cohen-
Jul 22, 2024He 77 Colhoun-
Jul 22, 2024He 76 Lambert-
Jul 22, 2024He 75 Schmidt-
Jul 22, 2024He 74 Soutar 1991-
Jul 22, 2024He 73 Lamon Fava-
Jul 22, 2024He 72 Anuurad-
Jul 22, 2024He 71 Rader 1995-
Jul 22, 2024He 70 Hobbs 1999-
Jul 22, 2024He 69 Kolski-
Jul 22, 2024He 68 Koschinsky And Boffa-
Jul 22, 2024He 67 Kochinsky And Marcovina-
Jul 22, 2024He 66 Jacobson-
Jul 22, 2024He 65 Dube-
Jul 22, 2024He 64 Clarke-
Jul 22, 2024He 63 Kamstrup-
Jul 22, 2024He 62 Tregouet-
Jul 22, 2024He 61 Davignon-
Jul 22, 2024He 60 Lippi-
Jul 22, 2024He 59 Bonny Eingetreten Im November Sanofi Biotechnology Sas (Fr)-
Jul 22, 2024He 59A En-
Jul 22, 2024He 58 Confirmation Of Power To Act July 16-
Jul 22, 2024He 58A Coury Witness Statement 18 July-
Jul 22, 2024He 57 Laurent Gilhodes As Chairman Of Sanofi Biotechnologies Sas (Fr)-
Jul 22, 2024He 57A En-
Jul 22, 2024He 56 Second Confirmatory License Agreement-
Jul 22, 2024He 55 Poa Executed By Gilhodes (Fr)-
Jul 22, 2024He 55A En-
Jul 22, 2024He 54 Form 8 K Filing To Us Sec April 7-
Jul 22, 2024He 53 2Nd Parhofer Declaration Infringment-
Jul 22, 2024He 52 Smpc Atorvastatin (De)-
Jul 22, 2024He 51 Chmp-
Jul 22, 2024He 51A Report From The Cmdh Meeting Held On 16Th 17Th And 18Th January-
Jul 22, 2024He 50 Statement Of Defence (De)-
Jul 22, 2024He 50A En-
Jul 22, 2024He 49 Smpc Training Presentation Of The Emas Smpc Advisory Group-
Jul 22, 2024He 48 C Ronse-
Jul 22, 2024He 47 Paris 20 Ocober 1913662 (Fr)-
Jul 22, 2024He 47A En-
Jul 22, 2024He 46 O Donoghue Et Al Circulation-
Jul 22, 2024He 46A O Donoghue Et Al Supplemental Material-
Jul 22, 2024He 45 Amgens Reply Of 25 April-
Jul 22, 2024He 45A En-
Jul 22, 2024He 40B Verification Of Electronic Signatures For He 40-
Jul 22, 2024He 38A Verification Of Electronic Signatures For He 38-
Jul 22, 2024He 103 Stein-
Jul 22, 2024He 102 Smpc For Praluent ()-
Jul 22, 2024He 101 Smpc For Repatha ()-
Jul 22, 2024He 100 Summary Of Pre Priority Clinical Trials Using Anti Pcsk9 Antibodies-
Jul 22, 2024Ar 5 Clean-
Jul 22, 2024Ar 5B Amended Description-
Jul 22, 2024Ar 5A Tracked-
Jul 22, 2024Ar 4 Clean-
Jul 22, 2024Ar 4B Amended Description-
Jul 22, 2024Ar 4A Tracked-
Jul 22, 2024Ar 3 Clean-
Jul 22, 2024Ar 3B Amended Description-
Jul 22, 2024Ar 3A Tracked-
Jul 22, 2024Ar 2 Clean-
Jul 22, 2024Ar 2B Amended Description-
Jul 22, 2024Ar 2A Tracked-
Jul 22, 2024Ar 1 Clean-
Jul 22, 2024Ar 1B Amended Description-
Jul 22, 2024Ar 1A Tracked-
Jul 22, 2024Acknowledgement Of Lodging-
Jul 1, 2024Response On Time Extension Request From Sanofi-
Jul 1, 2024Procedural Order Extension Time Limit
Jul 1, 2024Outcome Of The Order-
Jun 26, 2024Receipt-
Jun 26, 2024Opportunity To Comment-
Jun 25, 2024.06.25 Request For An Extension-
Jun 20, 2024Fruther Brief Re Preliminary Objection En-
Jun 20, 2024Exhibit Bp74-
Jun 18, 2024He 44 Rc Dusseldorf Order Of 3 May-
Jun 18, 2024He 44A Translation He 44-
Jun 18, 2024He 43 Rc Dusseldorf Order Of 13 May-
Jun 18, 2024He 43A Translation He 43-
Jun 18, 2024240517 Notice Re Preliminary Objection Sgn-
Jun 17, 2024Case Management Preliminary Objection-
May 21, 2024Request To Produce Evidence-
May 21, 2024Receipt-
May 17, 2024Receipt-
May 17, 2024Notice Re Po-
May 17, 2024He 44A-
May 17, 2024He 44-
May 17, 2024He 43A-
May 17, 2024He 43-
May 6, 2024Formal Checks Notification Of Positive Outcome-
May 3, 2024Statement Of Defense And Counterclaim For Revocation Amgen May 3 2024 En Signed-
May 3, 2024Statement Of Defense-
May 3, 2024Exhibit Bp9-
May 3, 2024Exhibit Bp8-
May 3, 2024Exhibit Bp73 Amgen En-
May 3, 2024Exhibit Bp73-
May 3, 2024Exhibit Bp72 Amgen En-
May 3, 2024Exhibit Bp72-
May 3, 2024Exhibit Bp71 Amgen En-
May 3, 2024Exhibit Bp71-
May 3, 2024Exhibit Bp70 Amgen De-
May 3, 2024Exhibit Bp70A Amgen En-
May 3, 2024Exhibit Bp70A-
May 3, 2024Exhibit Bp70-
May 3, 2024Exhibit Bp7-
May 3, 2024Exhibit Bp6 Part 4-
May 3, 2024Exhibit Bp6 Part 3-
May 3, 2024Exhibit Bp6 Part 2-
May 3, 2024Exhibit Bp6 Part 1-
May 3, 2024Exhibit Bp69 Amgen Be-
May 3, 2024Exhibit Bp69A Amgen En-
May 3, 2024Exhibit Bp69A-
May 3, 2024Exhibit Bp69-
May 3, 2024Exhibit Bp68 Amgen It-
May 3, 2024Exhibit Bp68A Amgen En-
May 3, 2024Exhibit Bp68A-
May 3, 2024Exhibit Bp68-
May 3, 2024Exhibit Bp67 Amgen Fr-
May 3, 2024Exhibit Bp67A Amgen En-
May 3, 2024Exhibit Bp67A-
May 3, 2024Exhibit Bp67-
May 3, 2024Exhibit Bp66 Amgen Nl-
May 3, 2024Exhibit Bp66A Amgen En-
May 3, 2024Exhibit Bp66A-
May 3, 2024Exhibit Bp66-
May 3, 2024Exhibit Bp65 Amgen En-
May 3, 2024Exhibit Bp65-
May 3, 2024Exhibit Bp64 Amgen De-
May 3, 2024Exhibit Bp64A Amgen En-
May 3, 2024Exhibit Bp64A-
May 3, 2024Exhibit Bp64-
May 3, 2024Exhibit Bp63 Amgen De-
May 3, 2024Exhibit Bp63A Amgen En-
May 3, 2024Exhibit Bp63A-
May 3, 2024Exhibit Bp63-
May 3, 2024Exhibit Bp62 Amgen De-
May 3, 2024Exhibit Bp62-
May 3, 2024Exhibit Bp61 Amgen En-
May 3, 2024Exhibit Bp61-
May 3, 2024Exhibit Bp60 Amgen De-
May 3, 2024Exhibit Bp60A Amgen En-
May 3, 2024Exhibit Bp60A-
May 3, 2024Exhibit Bp60-
May 3, 2024Exhibit Bp59 Amgen En-
May 3, 2024Exhibit Bp59-
May 3, 2024Exhibit Bp58 Amgen En-
May 3, 2024Exhibit Bp58-
May 3, 2024Exhibit Bp57 Amgen En-
May 3, 2024Exhibit Bp57-
May 3, 2024Exhibit Bp56 Part 2-
May 3, 2024Exhibit Bp56 Part 1-
May 3, 2024Exhibit Bp56 Amgen Part 2 Fr-
May 3, 2024Exhibit Bp56 Amgen Part 1 Fr-
May 3, 2024Exhibit Bp56A Amgen En-
May 3, 2024Exhibit Bp56A-
May 3, 2024Exhibit Bp55 Amgen En-
May 3, 2024Exhibit Bp55-
May 3, 2024Exhibit Bp54 Amgen En-
May 3, 2024Exhibit Bp54-
May 3, 2024Exhibit Bp53 Amgen De-
May 3, 2024Exhibit Bp53A Amgen En-
May 3, 2024Exhibit Bp53A-
May 3, 2024Exhibit Bp53-
May 3, 2024Exhibit Bp52 Amgen De-
May 3, 2024Exhibit Bp52A Amgen En-
May 3, 2024Exhibit Bp52A-
May 3, 2024Exhibit Bp52-
May 3, 2024Exhibit Bp51 Amgen It-
May 3, 2024Exhibit Bp51A Amgen En-
May 3, 2024Exhibit Bp51A-
May 3, 2024Exhibit Bp51-
May 3, 2024Exhibit Bp50 Amgen Fr-
May 3, 2024Exhibit Bp50A Amgen En-
May 3, 2024Exhibit Bp50A-
May 3, 2024Exhibit Bp50-
May 3, 2024Exhibit Bp5-
May 3, 2024Exhibit Bp49 Amgen Fr-
May 3, 2024Exhibit Bp49A Amgen En-
May 3, 2024Exhibit Bp49A-
May 3, 2024Exhibit Bp49-
May 3, 2024Exhibit Bp48 Amgen Fr-
May 3, 2024Exhibit Bp48A Amgen En-
May 3, 2024Exhibit Bp48A-
May 3, 2024Exhibit Bp48-
May 3, 2024Exhibit Bp47 Amgen Nl-
May 3, 2024Exhibit Bp47A Amgen En-
May 3, 2024Exhibit Bp47A-
May 3, 2024Exhibit Bp47-
May 3, 2024Exhibit Bp46 Amgen Nl-
May 3, 2024Exhibit Bp46A Amgen En-
May 3, 2024Exhibit Bp46A-
May 3, 2024Exhibit Bp46-
May 3, 2024Exhibit Bp45 Amgen En-
May 3, 2024Exhibit Bp45-
May 3, 2024Exhibit Bp44 Amgen En-
May 3, 2024Exhibit Bp44-
May 3, 2024Exhibit Bp43 Amgen En-
May 3, 2024Exhibit Bp43-
May 3, 2024Exhibit Bp42 Amgen En-
May 3, 2024Exhibit Bp42-
May 3, 2024Exhibit Bp41 Amgen En-
May 3, 2024Exhibit Bp41-
May 3, 2024Exhibit Bp40 Amgen En-
May 3, 2024Exhibit Bp40-
May 3, 2024Exhibit Bp39 Amgen En-
May 3, 2024Exhibit Bp39-
May 3, 2024Exhibit Bp38 Amgen En-
May 3, 2024Exhibit Bp38-
May 3, 2024Exhibit Bp37 Amgen En-
May 3, 2024Exhibit Bp37-
May 3, 2024Exhibit Bp36 Amgen En-
May 3, 2024Exhibit Bp36-
May 3, 2024Exhibit Bp35 Amgen En-
May 3, 2024Exhibit Bp35-
May 3, 2024Exhibit Bp34 Amgen En-
May 3, 2024Exhibit Bp34A Amgen En-
May 3, 2024Exhibit Bp34A-
May 3, 2024Exhibit Bp34-
May 3, 2024Exhibit Bp33 Amgen De-
May 3, 2024Exhibit Bp33A Amgen En-
May 3, 2024Exhibit Bp33A-
May 3, 2024Exhibit Bp33-
May 3, 2024Exhibit Bp32 Amgen En-
May 3, 2024Exhibit Bp32-
May 3, 2024Exhibit Bp31 Amgen En-
May 3, 2024Exhibit Bp31-
May 3, 2024Exhibit Bp30 Amgen En-
May 3, 2024Exhibit Bp30-
May 3, 2024Exhibit Bp29 Amgen En-
May 3, 2024Exhibit Bp29-
May 3, 2024Exhibit Bp28 Amgen En-
May 3, 2024Exhibit Bp28-
May 3, 2024Exhibit Bp27 Amgen En-
May 3, 2024Exhibit Bp27-
May 3, 2024Exhibit Bp26 Amgen En-
May 3, 2024Exhibit Bp26-
May 3, 2024Exhibit Bp25 Amgen En-
May 3, 2024Exhibit Bp25-
May 3, 2024Exhibit Bp24 Amgen En-
May 3, 2024Exhibit Bp24-
May 3, 2024Exhibit Bp23 Amgen En-
May 3, 2024Exhibit Bp23-
May 3, 2024Exhibit Bp22 Amgen En-
May 3, 2024Exhibit Bp22-
May 3, 2024Exhibit Bp21 Amgen En-
May 3, 2024Exhibit Bp21-
May 3, 2024Exhibit Bp20 Amgen En-
May 3, 2024Exhibit Bp20-
May 3, 2024Exhibit Bp19 Amgen En-
May 3, 2024Exhibit Bp19-
May 3, 2024Exhibit Bp18 Amgen En-
May 3, 2024Exhibit Bp18-
May 3, 2024Exhibit Bp17 Amgen En-
May 3, 2024Exhibit Bp17-
May 3, 2024Exhibit Bp16 Amgen En-
May 3, 2024Exhibit Bp16-
May 3, 2024Exhibit Bp15 Amgen En-
May 3, 2024Exhibit Bp15-
May 3, 2024Exhibit Bp14 Amgen En-
May 3, 2024Exhibit Bp14-
May 3, 2024Exhibit Bp13 Amgen En-
May 3, 2024Exhibit Bp13-
May 3, 2024Exhibit Bp12 Amgen En-
May 3, 2024Exhibit Bp12-
May 3, 2024Exhibit Bp11 Amgen En-
May 3, 2024Exhibit Bp11-
May 3, 2024Exhibit Bp10 Amgen En-
May 3, 2024Exhibit Bp10-
May 3, 2024Exhibit Bp09 Amgen En-
May 3, 2024Exhibit Bp08 Amgen En-
May 3, 2024Exhibit Bp07 Amgen En-
May 3, 2024Exhibit Bp06 Amgen Part 4 En-
May 3, 2024Exhibit Bp06 Amgen Part 3 En-
May 3, 2024Exhibit Bp06 Amgen Part 2 En-
May 3, 2024Exhibit Bp06 Amgen Part 1 En-
May 3, 2024Exhibit Bp05 Amgen En-
May 3, 2024Acknowledgement Of Lodging-
Mar 18, 2024Response To Preliminary Objection-
Mar 18, 2024Federal Patent Court, Summons And Preliminary Opinion In Accordance With Sec. 83 German Patent Act-
Mar 18, 2024Commentpreliminaryobjection-
Mar 4, 2024Preliminary Objection-
Mar 4, 2024Preliminaryobjection-
Mar 4, 2024Exhibit Bp04A-
Mar 4, 2024Exhibit Bp04-
Mar 4, 2024Exhibit Bp03A-
Mar 4, 2024Exhibit Bp03-
Mar 4, 2024Exhibit Bp02A-
Mar 4, 2024Exhibit Bp02-
Mar 4, 2024Exhibit Bp01A-
Mar 4, 2024Exhibit Bp01-
Feb 9, 2024Epouploaddocumentsworkflow-
Feb 9, 2024Document From Epo-
Feb 5, 2024Notification Of Service-
Feb 5, 2024Acknowledgement Of Access To Case-
Jan 25, 2024Receipt-
Jan 25, 2024Panel Appointment-
Jan 25, 2024Formal Checks Notification Of Positive Outcome-
Jan 25, 2024Epo Request For Case Pending-
Jan 10, 2024Proof Of Payment-
Jan 10, 2024He 9 Amgen S Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 8 Claimants Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 7 Board Of Appeal (T1927/22 3.3.04), Minutes Of The Hearing On 6 December-
Jan 10, 2024He 6 Board Of Appeal (T1927/22 3.3.04), Preliminary Opinion On Ep 004 Of 6 October-
Jan 10, 2024He 5 Opposition Division, Grounds For The Decision On Ep 004 Of 16 August-
Jan 10, 2024He 4 Notice On The Outcome Of The Opposition On Ep 004 Of 8/9 June-
Jan 10, 2024He 41 Appointment Alban De La Sabliere-
Jan 10, 2024He 40 Power Of Attorney John C. Conway (French)-
Jan 10, 2024He 40A Translation He 40 (En)-
Jan 10, 2024He 3 EP2756004B1-
Jan 10, 2024He 39 Appointment Larry Coury Secretary Certificate-
Jan 10, 2024He 38 Confirmatory License Agreement-
Jan 10, 2024He 37 Lauer Taxe Excerpt-
Jan 10, 2024He 36 Press Release Of Defendant 1) Of 21. February-
Jan 10, 2024He 35 Press Release Of Defendant 1) Of 21. July-
Jan 10, 2024He 34 EP2215124B9 (Excerpt)-
Jan 10, 2024He 33 Amgen Inc., Annual Report (10 K Filing) For Fiscal Year Ended December 31, (Excerpt)-
Jan 10, 2024He 32 Parhofer Kg Et Al, Drugs Real World Outcomes ; 6: 115 123-
Jan 10, 2024He 31 Ema, Chmp, Chmp DAY 120 List Of Questions, Evolocumab Amgen Europe B.V., Ema/Chmp/33068 (Excerpt)-
Jan 10, 2024He 30 Ema, Chmp, Assessment Report Repatha(R), Ema/Chmp/222019 (Excerpt)-
Jan 10, 2024He 2 Printouts From Patent Register [Bundle]-
Jan 10, 2024He 29 Cmdh Questions & Answers On Usage Patents, Cmdh/279, Rev. 1, May-
Jan 10, 2024He 28 Case T452/14, Laboratoires Ctrs V European Commission, Ecli:Eu:T::373-
Jan 10, 2024He 27 Ema S Guideline On Summary Of Product Characteristics (Smpc) Of September-
Jan 10, 2024He 26 Hoge Raad, Judgement Of 3 November , 15/04934, Ecli:Nl:Hr::2807-
Jan 10, 2024He 26A English Translation (En)-
Jan 10, 2024He 25 Higher Regional Court Of Dusseldorf, Grur , 279 Fulvestrant-
Jan 10, 2024He 25A Machine Translation (En)-
Jan 10, 2024He 24 Fachinformationen Repatha(R)-
Jan 10, 2024He 23 Smpc Of Repatha(R)-
Jan 10, 2024He 22 Website Https://Fachkreise.Amgen.De/Produkte/Repatha/Index-
Jan 10, 2024He 21 Expert Declaration Prof. Klaus G. Parhofer-
Jan 10, 2024He 20 F. Kronenberg Et Al., European Heart Journal () 43, 3925 3946-
Jan 10, 2024He 1 EP3536712B1-
Jan 10, 2024He 19 Wilson Et Al., Journal Of Clinical Lipidology () 13, 374 392-
Jan 10, 2024He 18 V Bermudez Et. Al, American Journal Of Therapeutics 17, 263 273 (2-
Jan 10, 2024He 17 Feature Analysis Patent In Suit-
Jan 10, 2024He 16 Jama. ;302(4):412 423. Doi:10.1001/Jama..1063 (Including Online Supplement)-
Jan 10, 2024He 15 Bennet Et Al, Arch Intern Med, VOL. 168, No. 6, ;-
Jan 10, 2024He 14 Expert Report I By Emanuele Di Angelantonio From The European Opposition Proceedings (D64)-
Jan 10, 2024He 13 Horton Et Al.,-
Jan 10, 2024He 12 Nordestgaard Et Al, European Heart Journal, 31, ,-
Jan 10, 2024He 11 Grounds For Defence To Nullity Action DATED 15 November-
Jan 10, 2024He 10 Amgen S Nullity Action On Ep 004 DATED 3 August Filed Before The Federal Patent Court (3 Ni 21/23)-
Jan 10, 2024Acknowledgement Of Lodging-
Jan 10, 2024240110 Statement Of Claim Sig-
Jun 27, 2025Receipt-
Jun 23, 2025250623 Request Re. Audio Recording-
Jun 16, 2025Workflow Closed
Jun 16, 2025Outcome Of The Order-
Jun 13, 2025Receipt-
Jun 13, 202520250613 Application Cost Decision Amgen-
May 13, 2025Headnote And Keywords-
May 13, 2025Final Decision
May 13, 2025Decisionoutcome-
Apr 30, 2025Outcome Of The Order-
Apr 30, 2025Confirmation Of Appointment
Apr 22, 2025Receipt-
Apr 17, 202520250417 Recording Of Oral Hearing Request Amgen En-
Apr 4, 2025Reschedule Announcement
Mar 3, 2025Request For Correction-
Mar 3, 2025Receipt-
Mar 3, 2025250227 Email Re Correction-
Mar 3, 2025250214 Order Correction Of Claimant'S Name-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S04-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S03-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S02-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S01-
Feb 21, 2025Summon Oral Hearing-
Feb 21, 2025Summary Of Citations-
Feb 21, 2025Response On Requests And Synoptical Table-
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure-
Feb 21, 2025Hearing Dates-
Feb 21, 2025Exhibit Bp 85 Amgen-
Feb 21, 202520250221 Table Of Exhibits And Request Ars Brief Amgen-
Feb 20, 2025Rejecting Time Extension
Feb 20, 2025Rectification Order-
Feb 20, 2025Outcome Of The Order-
Feb 20, 2025Course Of The Oral Hearing
Feb 19, 2025Written Procedure Closure-
Feb 19, 2025Template Order-
Feb 19, 2025Receipt-
Feb 19, 2025Outcome Of The Order-
Feb 19, 2025Order Interim Procedure
Feb 19, 2025Art. 33 3)(A) Upca
Feb 18, 2025Slides For The Hearing On 25 February-
Feb 18, 2025Request On Timing Of Complete Statement Of Claim-
Feb 18, 2025Receipt-
Feb 18, 2025Exhibit Bp84 Amgen-
Feb 18, 2025Cover Letter On Submssion Of Slides-
Feb 18, 202520250218 Response Amgen App 6226 2025-
Feb 18, 202520250218 Comment Re Cfr Amgen App 5925 2025 En Signed-
Feb 14, 2025Outcome Of The Order-
Feb 14, 2025Opportunity To Comment-
Feb 14, 2025Decision Regarding R.9 Request
Feb 14, 2025Correction Name
Feb 6, 2025Receipt-
Feb 5, 2025Receipt-
Feb 5, 2025He 116A-
Feb 5, 2025Application Pursuant To Rule 9.1 Rop-
Feb 5, 20253Rd Prof. Parhofer Declaration-
Feb 4, 2025Sanofi V Amgen Rule 336 Rop Request To File Demonstratives-
Feb 3, 2025Rectification
Jan 30, 2025Separation Of Proceedings
Jan 21, 2025Receipt-
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation-
Jan 20, 2025Receipt-
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action-
Dec 23, 2024R. 20.2 Rop Information
Dec 23, 2024Preliminary Objection Decisionoutcome-
Dec 13, 2024Order Set Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates-
Dec 5, 2024Panel Appointment-
Nov 29, 2024Outcome Of The Order-
Nov 29, 2024Order Inform Pcfi Allocation Tqj
Nov 14, 2024Receipt-
Nov 13, 2024Exhibit Bp83 Court Notice Re Re Scheduled Oral Hearing In Main Damages Case-
Nov 13, 2024Exhibit Bp82 Minutes Oral Hearing In Main Damages Case-
Nov 13, 2024Application To Comment Re. Scheduling Nov 13-
Nov 11, 2024He 115 241016 Munich Court Order-
Nov 11, 2024He 114 Confirmation Ski Rauline (Redacted)-
Nov 11, 2024241111 Comments-
Nov 11, 202420241111 Request For Hearing Date Brief Of Amgen-
Nov 5, 2024Pre Order Opportunity To Comment Oral Hearing Date-
Oct 21, 2024Receipt-
Oct 18, 2024EP857Reply To Amgen Response To Application For Leave To Amend Case (Signed)-
Oct 9, 2024Response To Application For Leave To Amend The Case R263-
Oct 9, 2024Receipt-
Oct 8, 2024241008 Submission On Lis Pendens-
Oct 4, 2024Receipt-
Oct 4, 2024Correction-
Oct 3, 2024Application-
Sep 26, 2024Order Opportunity To Comment-
Sep 25, 2024Receipt-
Sep 25, 2024He 107 Confirmatory License Agreement-
Sep 25, 2024He 105 Intention To Grant-
Sep 25, 2024He 104 Decision To Grant-
Sep 25, 2024Exhibit He 109-
Sep 25, 2024Exhibit He 108-
Sep 25, 2024Exhibit He 106-
Sep 25, 2024Application To Amend Case-
Sep 23, 2024Infringement Rejoinder And Validity Reply-
Sep 23, 2024Exhibit Bp81-
Sep 23, 2024Exhibit Bp80-
Sep 23, 2024Exhibit Bp79-
Sep 23, 2024Exhibit Bp78-
Sep 23, 2024Exhibit Bp77-
Sep 23, 2024Exhibit Bp76-
Sep 23, 2024Exhibit Bp75-
Sep 23, 2024Acknowledgement Of Lodging-
Jul 22, 2024Reply To Defence And Defence To Counterclaim-
Jul 22, 2024He 99 Szarek-
Jul 22, 2024He 98 Safarova-
Jul 22, 2024He 97 Declaration Of Prof Di Angelantonio-
Jul 22, 2024He 96 Swergold Poster-
Jul 22, 2024He 95 Lagor And Millar-
Jul 22, 2024He 94 Excerpt From Clinicaltrials Gov Amg145-
Jul 22, 2024He 93 Excerpt From Clinicaltrials Gov Gauss-
Jul 22, 2024He 92 Declaration Of Prof Parhofer On Validity-
Jul 22, 2024He 91 Nct012884443-
Jul 22, 2024He 90 Repatha Fda Approval-
Jul 22, 2024He 89 Praluent Fda Approval-
Jul 22, 2024He 88 Kamstrup-
Jul 22, 2024He 87 Jama-
Jul 22, 2024He 86 Cohen-
Jul 22, 2024He 85 Romangnuolo-
Jul 22, 2024He 84 Stroes-
Jul 22, 2024He 83 Albers (Aim High)-
Jul 22, 2024He 82 Willeit-
Jul 22, 2024He 81 Sabatine-
Jul 22, 2024He 80 Schwartz-
Jul 22, 2024He 79 Ober-
Jul 22, 2024He 78 Cohen-
Jul 22, 2024He 77 Colhoun-
Jul 22, 2024He 76 Lambert-
Jul 22, 2024He 75 Schmidt-
Jul 22, 2024He 74 Soutar 1991-
Jul 22, 2024He 73 Lamon Fava-
Jul 22, 2024He 72 Anuurad-
Jul 22, 2024He 71 Rader 1995-
Jul 22, 2024He 70 Hobbs 1999-
Jul 22, 2024He 69 Kolski-
Jul 22, 2024He 68 Koschinsky And Boffa-
Jul 22, 2024He 67 Kochinsky And Marcovina-
Jul 22, 2024He 66 Jacobson-
Jul 22, 2024He 65 Dube-
Jul 22, 2024He 64 Clarke-
Jul 22, 2024He 63 Kamstrup-
Jul 22, 2024He 62 Tregouet-
Jul 22, 2024He 61 Davignon-
Jul 22, 2024He 60 Lippi-
Jul 22, 2024He 59 Bonny Eingetreten Im November Sanofi Biotechnology Sas (Fr)-
Jul 22, 2024He 59A En-
Jul 22, 2024He 58 Confirmation Of Power To Act July 16-
Jul 22, 2024He 58A Coury Witness Statement 18 July-
Jul 22, 2024He 57 Laurent Gilhodes As Chairman Of Sanofi Biotechnologies Sas (Fr)-
Jul 22, 2024He 57A En-
Jul 22, 2024He 56 Second Confirmatory License Agreement-
Jul 22, 2024He 55 Poa Executed By Gilhodes (Fr)-
Jul 22, 2024He 55A En-
Jul 22, 2024He 54 Form 8 K Filing To Us Sec April 7-
Jul 22, 2024He 53 2Nd Parhofer Declaration Infringment-
Jul 22, 2024He 52 Smpc Atorvastatin (De)-
Jul 22, 2024He 51 Chmp-
Jul 22, 2024He 51A Report From The Cmdh Meeting Held On 16Th 17Th And 18Th January-
Jul 22, 2024He 50 Statement Of Defence (De)-
Jul 22, 2024He 50A En-
Jul 22, 2024He 49 Smpc Training Presentation Of The Emas Smpc Advisory Group-
Jul 22, 2024He 48 C Ronse-
Jul 22, 2024He 47 Paris 20 Ocober 1913662 (Fr)-
Jul 22, 2024He 47A En-
Jul 22, 2024He 46 O Donoghue Et Al Circulation-
Jul 22, 2024He 46A O Donoghue Et Al Supplemental Material-
Jul 22, 2024He 45 Amgens Reply Of 25 April-
Jul 22, 2024He 45A En-
Jul 22, 2024He 40B Verification Of Electronic Signatures For He 40-
Jul 22, 2024He 38A Verification Of Electronic Signatures For He 38-
Jul 22, 2024He 103 Stein-
Jul 22, 2024He 102 Smpc For Praluent ()-
Jul 22, 2024He 101 Smpc For Repatha ()-
Jul 22, 2024He 100 Summary Of Pre Priority Clinical Trials Using Anti Pcsk9 Antibodies-
Jul 22, 2024Ar 5 Clean-
Jul 22, 2024Ar 5B Amended Description-
Jul 22, 2024Ar 5A Tracked-
Jul 22, 2024Ar 4 Clean-
Jul 22, 2024Ar 4B Amended Description-
Jul 22, 2024Ar 4A Tracked-
Jul 22, 2024Ar 3 Clean-
Jul 22, 2024Ar 3B Amended Description-
Jul 22, 2024Ar 3A Tracked-
Jul 22, 2024Ar 2 Clean-
Jul 22, 2024Ar 2B Amended Description-
Jul 22, 2024Ar 2A Tracked-
Jul 22, 2024Ar 1 Clean-
Jul 22, 2024Ar 1B Amended Description-
Jul 22, 2024Ar 1A Tracked-
Jul 22, 2024Acknowledgement Of Lodging-
Jul 1, 2024Response On Time Extension Request From Sanofi-
Jul 1, 2024Procedural Order Extension Time Limit
Jul 1, 2024Outcome Of The Order-
Jun 26, 2024Receipt-
Jun 26, 2024Opportunity To Comment-
Jun 25, 2024.06.25 Request For An Extension-
Jun 20, 2024Fruther Brief Re Preliminary Objection En-
Jun 20, 2024Exhibit Bp74-
Jun 18, 2024He 44 Rc Dusseldorf Order Of 3 May-
Jun 18, 2024He 44A Translation He 44-
Jun 18, 2024He 43 Rc Dusseldorf Order Of 13 May-
Jun 18, 2024He 43A Translation He 43-
Jun 18, 2024240517 Notice Re Preliminary Objection Sgn-
Jun 17, 2024Case Management Preliminary Objection-
May 21, 2024Request To Produce Evidence-
May 21, 2024Receipt-
May 17, 2024Receipt-
May 17, 2024Notice Re Po-
May 17, 2024He 44A-
May 17, 2024He 44-
May 17, 2024He 43A-
May 17, 2024He 43-
May 6, 2024Formal Checks Notification Of Positive Outcome-
May 3, 2024Statement Of Defense And Counterclaim For Revocation Amgen May 3 2024 En Signed-
May 3, 2024Statement Of Defense-
May 3, 2024Exhibit Bp9-
May 3, 2024Exhibit Bp8-
May 3, 2024Exhibit Bp73 Amgen En-
May 3, 2024Exhibit Bp73-
May 3, 2024Exhibit Bp72 Amgen En-
May 3, 2024Exhibit Bp72-
May 3, 2024Exhibit Bp71 Amgen En-
May 3, 2024Exhibit Bp71-
May 3, 2024Exhibit Bp70 Amgen De-
May 3, 2024Exhibit Bp70A Amgen En-
May 3, 2024Exhibit Bp70A-
May 3, 2024Exhibit Bp70-
May 3, 2024Exhibit Bp7-
May 3, 2024Exhibit Bp6 Part 4-
May 3, 2024Exhibit Bp6 Part 3-
May 3, 2024Exhibit Bp6 Part 2-
May 3, 2024Exhibit Bp6 Part 1-
May 3, 2024Exhibit Bp69 Amgen Be-
May 3, 2024Exhibit Bp69A Amgen En-
May 3, 2024Exhibit Bp69A-
May 3, 2024Exhibit Bp69-
May 3, 2024Exhibit Bp68 Amgen It-
May 3, 2024Exhibit Bp68A Amgen En-
May 3, 2024Exhibit Bp68A-
May 3, 2024Exhibit Bp68-
May 3, 2024Exhibit Bp67 Amgen Fr-
May 3, 2024Exhibit Bp67A Amgen En-
May 3, 2024Exhibit Bp67A-
May 3, 2024Exhibit Bp67-
May 3, 2024Exhibit Bp66 Amgen Nl-
May 3, 2024Exhibit Bp66A Amgen En-
May 3, 2024Exhibit Bp66A-
May 3, 2024Exhibit Bp66-
May 3, 2024Exhibit Bp65 Amgen En-
May 3, 2024Exhibit Bp65-
May 3, 2024Exhibit Bp64 Amgen De-
May 3, 2024Exhibit Bp64A Amgen En-
May 3, 2024Exhibit Bp64A-
May 3, 2024Exhibit Bp64-
May 3, 2024Exhibit Bp63 Amgen De-
May 3, 2024Exhibit Bp63A Amgen En-
May 3, 2024Exhibit Bp63A-
May 3, 2024Exhibit Bp63-
May 3, 2024Exhibit Bp62 Amgen De-
May 3, 2024Exhibit Bp62-
May 3, 2024Exhibit Bp61 Amgen En-
May 3, 2024Exhibit Bp61-
May 3, 2024Exhibit Bp60 Amgen De-
May 3, 2024Exhibit Bp60A Amgen En-
May 3, 2024Exhibit Bp60A-
May 3, 2024Exhibit Bp60-
May 3, 2024Exhibit Bp59 Amgen En-
May 3, 2024Exhibit Bp59-
May 3, 2024Exhibit Bp58 Amgen En-
May 3, 2024Exhibit Bp58-
May 3, 2024Exhibit Bp57 Amgen En-
May 3, 2024Exhibit Bp57-
May 3, 2024Exhibit Bp56 Part 2-
May 3, 2024Exhibit Bp56 Part 1-
May 3, 2024Exhibit Bp56 Amgen Part 2 Fr-
May 3, 2024Exhibit Bp56 Amgen Part 1 Fr-
May 3, 2024Exhibit Bp56A Amgen En-
May 3, 2024Exhibit Bp56A-
May 3, 2024Exhibit Bp55 Amgen En-
May 3, 2024Exhibit Bp55-
May 3, 2024Exhibit Bp54 Amgen En-
May 3, 2024Exhibit Bp54-
May 3, 2024Exhibit Bp53 Amgen De-
May 3, 2024Exhibit Bp53A Amgen En-
May 3, 2024Exhibit Bp53A-
May 3, 2024Exhibit Bp53-
May 3, 2024Exhibit Bp52 Amgen De-
May 3, 2024Exhibit Bp52A Amgen En-
May 3, 2024Exhibit Bp52A-
May 3, 2024Exhibit Bp52-
May 3, 2024Exhibit Bp51 Amgen It-
May 3, 2024Exhibit Bp51A Amgen En-
May 3, 2024Exhibit Bp51A-
May 3, 2024Exhibit Bp51-
May 3, 2024Exhibit Bp50 Amgen Fr-
May 3, 2024Exhibit Bp50A Amgen En-
May 3, 2024Exhibit Bp50A-
May 3, 2024Exhibit Bp50-
May 3, 2024Exhibit Bp5-
May 3, 2024Exhibit Bp49 Amgen Fr-
May 3, 2024Exhibit Bp49A Amgen En-
May 3, 2024Exhibit Bp49A-
May 3, 2024Exhibit Bp49-
May 3, 2024Exhibit Bp48 Amgen Fr-
May 3, 2024Exhibit Bp48A Amgen En-
May 3, 2024Exhibit Bp48A-
May 3, 2024Exhibit Bp48-
May 3, 2024Exhibit Bp47 Amgen Nl-
May 3, 2024Exhibit Bp47A Amgen En-
May 3, 2024Exhibit Bp47A-
May 3, 2024Exhibit Bp47-
May 3, 2024Exhibit Bp46 Amgen Nl-
May 3, 2024Exhibit Bp46A Amgen En-
May 3, 2024Exhibit Bp46A-
May 3, 2024Exhibit Bp46-
May 3, 2024Exhibit Bp45 Amgen En-
May 3, 2024Exhibit Bp45-
May 3, 2024Exhibit Bp44 Amgen En-
May 3, 2024Exhibit Bp44-
May 3, 2024Exhibit Bp43 Amgen En-
May 3, 2024Exhibit Bp43-
May 3, 2024Exhibit Bp42 Amgen En-
May 3, 2024Exhibit Bp42-
May 3, 2024Exhibit Bp41 Amgen En-
May 3, 2024Exhibit Bp41-
May 3, 2024Exhibit Bp40 Amgen En-
May 3, 2024Exhibit Bp40-
May 3, 2024Exhibit Bp39 Amgen En-
May 3, 2024Exhibit Bp39-
May 3, 2024Exhibit Bp38 Amgen En-
May 3, 2024Exhibit Bp38-
May 3, 2024Exhibit Bp37 Amgen En-
May 3, 2024Exhibit Bp37-
May 3, 2024Exhibit Bp36 Amgen En-
May 3, 2024Exhibit Bp36-
May 3, 2024Exhibit Bp35 Amgen En-
May 3, 2024Exhibit Bp35-
May 3, 2024Exhibit Bp34 Amgen En-
May 3, 2024Exhibit Bp34A Amgen En-
May 3, 2024Exhibit Bp34A-
May 3, 2024Exhibit Bp34-
May 3, 2024Exhibit Bp33 Amgen De-
May 3, 2024Exhibit Bp33A Amgen En-
May 3, 2024Exhibit Bp33A-
May 3, 2024Exhibit Bp33-
May 3, 2024Exhibit Bp32 Amgen En-
May 3, 2024Exhibit Bp32-
May 3, 2024Exhibit Bp31 Amgen En-
May 3, 2024Exhibit Bp31-
May 3, 2024Exhibit Bp30 Amgen En-
May 3, 2024Exhibit Bp30-
May 3, 2024Exhibit Bp29 Amgen En-
May 3, 2024Exhibit Bp29-
May 3, 2024Exhibit Bp28 Amgen En-
May 3, 2024Exhibit Bp28-
May 3, 2024Exhibit Bp27 Amgen En-
May 3, 2024Exhibit Bp27-
May 3, 2024Exhibit Bp26 Amgen En-
May 3, 2024Exhibit Bp26-
May 3, 2024Exhibit Bp25 Amgen En-
May 3, 2024Exhibit Bp25-
May 3, 2024Exhibit Bp24 Amgen En-
May 3, 2024Exhibit Bp24-
May 3, 2024Exhibit Bp23 Amgen En-
May 3, 2024Exhibit Bp23-
May 3, 2024Exhibit Bp22 Amgen En-
May 3, 2024Exhibit Bp22-
May 3, 2024Exhibit Bp21 Amgen En-
May 3, 2024Exhibit Bp21-
May 3, 2024Exhibit Bp20 Amgen En-
May 3, 2024Exhibit Bp20-
May 3, 2024Exhibit Bp19 Amgen En-
May 3, 2024Exhibit Bp19-
May 3, 2024Exhibit Bp18 Amgen En-
May 3, 2024Exhibit Bp18-
May 3, 2024Exhibit Bp17 Amgen En-
May 3, 2024Exhibit Bp17-
May 3, 2024Exhibit Bp16 Amgen En-
May 3, 2024Exhibit Bp16-
May 3, 2024Exhibit Bp15 Amgen En-
May 3, 2024Exhibit Bp15-
May 3, 2024Exhibit Bp14 Amgen En-
May 3, 2024Exhibit Bp14-
May 3, 2024Exhibit Bp13 Amgen En-
May 3, 2024Exhibit Bp13-
May 3, 2024Exhibit Bp12 Amgen En-
May 3, 2024Exhibit Bp12-
May 3, 2024Exhibit Bp11 Amgen En-
May 3, 2024Exhibit Bp11-
May 3, 2024Exhibit Bp10 Amgen En-
May 3, 2024Exhibit Bp10-
May 3, 2024Exhibit Bp09 Amgen En-
May 3, 2024Exhibit Bp08 Amgen En-
May 3, 2024Exhibit Bp07 Amgen En-
May 3, 2024Exhibit Bp06 Amgen Part 4 En-
May 3, 2024Exhibit Bp06 Amgen Part 3 En-
May 3, 2024Exhibit Bp06 Amgen Part 2 En-
May 3, 2024Exhibit Bp06 Amgen Part 1 En-
May 3, 2024Exhibit Bp05 Amgen En-
May 3, 2024Acknowledgement Of Lodging-
Mar 18, 2024Response To Preliminary Objection-
Mar 18, 2024Federal Patent Court, Summons And Preliminary Opinion In Accordance With Sec. 83 German Patent Act-
Mar 18, 2024Commentpreliminaryobjection-
Mar 4, 2024Preliminary Objection-
Mar 4, 2024Preliminaryobjection-
Mar 4, 2024Exhibit Bp04A-
Mar 4, 2024Exhibit Bp04-
Mar 4, 2024Exhibit Bp03A-
Mar 4, 2024Exhibit Bp03-
Mar 4, 2024Exhibit Bp02A-
Mar 4, 2024Exhibit Bp02-
Mar 4, 2024Exhibit Bp01A-
Mar 4, 2024Exhibit Bp01-
Feb 9, 2024Epouploaddocumentsworkflow-
Feb 9, 2024Document From Epo-
Feb 5, 2024Notification Of Service-
Feb 5, 2024Acknowledgement Of Access To Case-
Jan 25, 2024Receipt-
Jan 25, 2024Panel Appointment-
Jan 25, 2024Formal Checks Notification Of Positive Outcome-
Jan 25, 2024Epo Request For Case Pending-
Jan 10, 2024Proof Of Payment-
Jan 10, 2024He 9 Amgen S Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 8 Claimants Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 7 Board Of Appeal (T1927/22 3.3.04), Minutes Of The Hearing On 6 December-
Jan 10, 2024He 6 Board Of Appeal (T1927/22 3.3.04), Preliminary Opinion On Ep 004 Of 6 October-
Jan 10, 2024He 5 Opposition Division, Grounds For The Decision On Ep 004 Of 16 August-
Jan 10, 2024He 4 Notice On The Outcome Of The Opposition On Ep 004 Of 8/9 June-
Jan 10, 2024He 41 Appointment Alban De La Sabliere-
Jan 10, 2024He 40 Power Of Attorney John C. Conway (French)-
Jan 10, 2024He 40A Translation He 40 (En)-
Jan 10, 2024He 3 EP2756004B1-
Jan 10, 2024He 39 Appointment Larry Coury Secretary Certificate-
Jan 10, 2024He 38 Confirmatory License Agreement-
Jan 10, 2024He 37 Lauer Taxe Excerpt-
Jan 10, 2024He 36 Press Release Of Defendant 1) Of 21. February-
Jan 10, 2024He 35 Press Release Of Defendant 1) Of 21. July-
Jan 10, 2024He 34 EP2215124B9 (Excerpt)-
Jan 10, 2024He 33 Amgen Inc., Annual Report (10 K Filing) For Fiscal Year Ended December 31, (Excerpt)-
Jan 10, 2024He 32 Parhofer Kg Et Al, Drugs Real World Outcomes ; 6: 115 123-
Jan 10, 2024He 31 Ema, Chmp, Chmp DAY 120 List Of Questions, Evolocumab Amgen Europe B.V., Ema/Chmp/33068 (Excerpt)-
Jan 10, 2024He 30 Ema, Chmp, Assessment Report Repatha(R), Ema/Chmp/222019 (Excerpt)-
Jan 10, 2024He 2 Printouts From Patent Register [Bundle]-
Jan 10, 2024He 29 Cmdh Questions & Answers On Usage Patents, Cmdh/279, Rev. 1, May-
Jan 10, 2024He 28 Case T452/14, Laboratoires Ctrs V European Commission, Ecli:Eu:T::373-
Jan 10, 2024He 27 Ema S Guideline On Summary Of Product Characteristics (Smpc) Of September-
Jan 10, 2024He 26 Hoge Raad, Judgement Of 3 November , 15/04934, Ecli:Nl:Hr::2807-
Jan 10, 2024He 26A English Translation (En)-
Jan 10, 2024He 25 Higher Regional Court Of Dusseldorf, Grur , 279 Fulvestrant-
Jan 10, 2024He 25A Machine Translation (En)-
Jan 10, 2024He 24 Fachinformationen Repatha(R)-
Jan 10, 2024He 23 Smpc Of Repatha(R)-
Jan 10, 2024He 22 Website Https://Fachkreise.Amgen.De/Produkte/Repatha/Index-
Jan 10, 2024He 21 Expert Declaration Prof. Klaus G. Parhofer-
Jan 10, 2024He 20 F. Kronenberg Et Al., European Heart Journal () 43, 3925 3946-
Jan 10, 2024He 1 EP3536712B1-
Jan 10, 2024He 19 Wilson Et Al., Journal Of Clinical Lipidology () 13, 374 392-
Jan 10, 2024He 18 V Bermudez Et. Al, American Journal Of Therapeutics 17, 263 273 (2-
Jan 10, 2024He 17 Feature Analysis Patent In Suit-
Jan 10, 2024He 16 Jama. ;302(4):412 423. Doi:10.1001/Jama..1063 (Including Online Supplement)-
Jan 10, 2024He 15 Bennet Et Al, Arch Intern Med, VOL. 168, No. 6, ;-
Jan 10, 2024He 14 Expert Report I By Emanuele Di Angelantonio From The European Opposition Proceedings (D64)-
Jan 10, 2024He 13 Horton Et Al.,-
Jan 10, 2024He 12 Nordestgaard Et Al, European Heart Journal, 31, ,-
Jan 10, 2024He 11 Grounds For Defence To Nullity Action DATED 15 November-
Jan 10, 2024He 10 Amgen S Nullity Action On Ep 004 DATED 3 August Filed Before The Federal Patent Court (3 Ni 21/23)-
Jan 10, 2024Acknowledgement Of Lodging-
Jan 10, 2024240110 Statement Of Claim Sig-
Jun 27, 2025Receipt-
Jun 23, 2025250623 Request Re. Audio Recording-
Jun 16, 2025Workflow Closed
Jun 16, 2025Outcome Of The Order-
Jun 13, 2025Receipt-
Jun 13, 202520250613 Application Cost Decision Amgen-
May 13, 2025Headnote And Keywords-
May 13, 2025Final Decision
May 13, 2025Decisionoutcome-
Apr 30, 2025Outcome Of The Order-
Apr 30, 2025Confirmation Of Appointment
Apr 22, 2025Receipt-
Apr 17, 202520250417 Recording Of Oral Hearing Request Amgen En-
Apr 4, 2025Reschedule Announcement
Mar 3, 2025Request For Correction-
Mar 3, 2025Receipt-
Mar 3, 2025250227 Email Re Correction-
Mar 3, 2025250214 Order Correction Of Claimant'S Name-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S04-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S03-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S02-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S01-
Feb 21, 2025Summon Oral Hearing-
Feb 21, 2025Summary Of Citations-
Feb 21, 2025Response On Requests And Synoptical Table-
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure-
Feb 21, 2025Hearing Dates-
Feb 21, 2025Exhibit Bp 85 Amgen-
Feb 21, 202520250221 Table Of Exhibits And Request Ars Brief Amgen-
Feb 20, 2025Rejecting Time Extension
Feb 20, 2025Rectification Order-
Feb 20, 2025Outcome Of The Order-
Feb 20, 2025Course Of The Oral Hearing
Feb 19, 2025Written Procedure Closure-
Feb 19, 2025Template Order-
Feb 19, 2025Receipt-
Feb 19, 2025Outcome Of The Order-
Feb 19, 2025Order Interim Procedure
Feb 19, 2025Art. 33 3)(A) Upca
Feb 18, 2025Slides For The Hearing On 25 February-
Feb 18, 2025Request On Timing Of Complete Statement Of Claim-
Feb 18, 2025Receipt-
Feb 18, 2025Exhibit Bp84 Amgen-
Feb 18, 2025Cover Letter On Submssion Of Slides-
Feb 18, 202520250218 Response Amgen App 6226 2025-
Feb 18, 202520250218 Comment Re Cfr Amgen App 5925 2025 En Signed-
Feb 14, 2025Outcome Of The Order-
Feb 14, 2025Opportunity To Comment-
Feb 14, 2025Decision Regarding R.9 Request
Feb 14, 2025Correction Name
Feb 6, 2025Receipt-
Feb 5, 2025Receipt-
Feb 5, 2025He 116A-
Feb 5, 2025Application Pursuant To Rule 9.1 Rop-
Feb 5, 20253Rd Prof. Parhofer Declaration-
Feb 4, 2025Sanofi V Amgen Rule 336 Rop Request To File Demonstratives-
Feb 3, 2025Rectification
Jan 30, 2025Separation Of Proceedings
Jan 21, 2025Receipt-
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation-
Jan 20, 2025Receipt-
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action-
Dec 23, 2024R. 20.2 Rop Information
Dec 23, 2024Preliminary Objection Decisionoutcome-
Dec 13, 2024Order Set Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates-
Dec 5, 2024Panel Appointment-
Nov 29, 2024Outcome Of The Order-
Nov 29, 2024Order Inform Pcfi Allocation Tqj
Nov 14, 2024Receipt-
Nov 13, 2024Exhibit Bp83 Court Notice Re Re Scheduled Oral Hearing In Main Damages Case-
Nov 13, 2024Exhibit Bp82 Minutes Oral Hearing In Main Damages Case-
Nov 13, 2024Application To Comment Re. Scheduling Nov 13-
Nov 11, 2024He 115 241016 Munich Court Order-
Nov 11, 2024He 114 Confirmation Ski Rauline (Redacted)-
Nov 11, 2024241111 Comments-
Nov 11, 202420241111 Request For Hearing Date Brief Of Amgen-
Nov 5, 2024Pre Order Opportunity To Comment Oral Hearing Date-
Oct 21, 2024Receipt-
Oct 18, 2024EP857Reply To Amgen Response To Application For Leave To Amend Case (Signed)-
Oct 9, 2024Response To Application For Leave To Amend The Case R263-
Oct 9, 2024Receipt-
Oct 8, 2024241008 Submission On Lis Pendens-
Oct 4, 2024Receipt-
Oct 4, 2024Correction-
Oct 3, 2024Application-
Sep 26, 2024Order Opportunity To Comment-
Sep 25, 2024Receipt-
Sep 25, 2024He 107 Confirmatory License Agreement-
Sep 25, 2024He 105 Intention To Grant-
Sep 25, 2024He 104 Decision To Grant-
Sep 25, 2024Exhibit He 109-
Sep 25, 2024Exhibit He 108-
Sep 25, 2024Exhibit He 106-
Sep 25, 2024Application To Amend Case-
Sep 23, 2024Infringement Rejoinder And Validity Reply-
Sep 23, 2024Exhibit Bp81-
Sep 23, 2024Exhibit Bp80-
Sep 23, 2024Exhibit Bp79-
Sep 23, 2024Exhibit Bp78-
Sep 23, 2024Exhibit Bp77-
Sep 23, 2024Exhibit Bp76-
Sep 23, 2024Exhibit Bp75-
Sep 23, 2024Acknowledgement Of Lodging-
Jul 22, 2024Reply To Defence And Defence To Counterclaim-
Jul 22, 2024He 99 Szarek-
Jul 22, 2024He 98 Safarova-
Jul 22, 2024He 97 Declaration Of Prof Di Angelantonio-
Jul 22, 2024He 96 Swergold Poster-
Jul 22, 2024He 95 Lagor And Millar-
Jul 22, 2024He 94 Excerpt From Clinicaltrials Gov Amg145-
Jul 22, 2024He 93 Excerpt From Clinicaltrials Gov Gauss-
Jul 22, 2024He 92 Declaration Of Prof Parhofer On Validity-
Jul 22, 2024He 91 Nct012884443-
Jul 22, 2024He 90 Repatha Fda Approval-
Jul 22, 2024He 89 Praluent Fda Approval-
Jul 22, 2024He 88 Kamstrup-
Jul 22, 2024He 87 Jama-
Jul 22, 2024He 86 Cohen-
Jul 22, 2024He 85 Romangnuolo-
Jul 22, 2024He 84 Stroes-
Jul 22, 2024He 83 Albers (Aim High)-
Jul 22, 2024He 82 Willeit-
Jul 22, 2024He 81 Sabatine-
Jul 22, 2024He 80 Schwartz-
Jul 22, 2024He 79 Ober-
Jul 22, 2024He 78 Cohen-
Jul 22, 2024He 77 Colhoun-
Jul 22, 2024He 76 Lambert-
Jul 22, 2024He 75 Schmidt-
Jul 22, 2024He 74 Soutar 1991-
Jul 22, 2024He 73 Lamon Fava-
Jul 22, 2024He 72 Anuurad-
Jul 22, 2024He 71 Rader 1995-
Jul 22, 2024He 70 Hobbs 1999-
Jul 22, 2024He 69 Kolski-
Jul 22, 2024He 68 Koschinsky And Boffa-
Jul 22, 2024He 67 Kochinsky And Marcovina-
Jul 22, 2024He 66 Jacobson-
Jul 22, 2024He 65 Dube-
Jul 22, 2024He 64 Clarke-
Jul 22, 2024He 63 Kamstrup-
Jul 22, 2024He 62 Tregouet-
Jul 22, 2024He 61 Davignon-
Jul 22, 2024He 60 Lippi-
Jul 22, 2024He 59 Bonny Eingetreten Im November Sanofi Biotechnology Sas (Fr)-
Jul 22, 2024He 59A En-
Jul 22, 2024He 58 Confirmation Of Power To Act July 16-
Jul 22, 2024He 58A Coury Witness Statement 18 July-
Jul 22, 2024He 57 Laurent Gilhodes As Chairman Of Sanofi Biotechnologies Sas (Fr)-
Jul 22, 2024He 57A En-
Jul 22, 2024He 56 Second Confirmatory License Agreement-
Jul 22, 2024He 55 Poa Executed By Gilhodes (Fr)-
Jul 22, 2024He 55A En-
Jul 22, 2024He 54 Form 8 K Filing To Us Sec April 7-
Jul 22, 2024He 53 2Nd Parhofer Declaration Infringment-
Jul 22, 2024He 52 Smpc Atorvastatin (De)-
Jul 22, 2024He 51 Chmp-
Jul 22, 2024He 51A Report From The Cmdh Meeting Held On 16Th 17Th And 18Th January-
Jul 22, 2024He 50 Statement Of Defence (De)-
Jul 22, 2024He 50A En-
Jul 22, 2024He 49 Smpc Training Presentation Of The Emas Smpc Advisory Group-
Jul 22, 2024He 48 C Ronse-
Jul 22, 2024He 47 Paris 20 Ocober 1913662 (Fr)-
Jul 22, 2024He 47A En-
Jul 22, 2024He 46 O Donoghue Et Al Circulation-
Jul 22, 2024He 46A O Donoghue Et Al Supplemental Material-
Jul 22, 2024He 45 Amgens Reply Of 25 April-
Jul 22, 2024He 45A En-
Jul 22, 2024He 40B Verification Of Electronic Signatures For He 40-
Jul 22, 2024He 38A Verification Of Electronic Signatures For He 38-
Jul 22, 2024He 103 Stein-
Jul 22, 2024He 102 Smpc For Praluent ()-
Jul 22, 2024He 101 Smpc For Repatha ()-
Jul 22, 2024He 100 Summary Of Pre Priority Clinical Trials Using Anti Pcsk9 Antibodies-
Jul 22, 2024Ar 5 Clean-
Jul 22, 2024Ar 5B Amended Description-
Jul 22, 2024Ar 5A Tracked-
Jul 22, 2024Ar 4 Clean-
Jul 22, 2024Ar 4B Amended Description-
Jul 22, 2024Ar 4A Tracked-
Jul 22, 2024Ar 3 Clean-
Jul 22, 2024Ar 3B Amended Description-
Jul 22, 2024Ar 3A Tracked-
Jul 22, 2024Ar 2 Clean-
Jul 22, 2024Ar 2B Amended Description-
Jul 22, 2024Ar 2A Tracked-
Jul 22, 2024Ar 1 Clean-
Jul 22, 2024Ar 1B Amended Description-
Jul 22, 2024Ar 1A Tracked-
Jul 22, 2024Acknowledgement Of Lodging-
Jul 1, 2024Response On Time Extension Request From Sanofi-
Jul 1, 2024Procedural Order Extension Time Limit
Jul 1, 2024Outcome Of The Order-
Jun 26, 2024Receipt-
Jun 26, 2024Opportunity To Comment-
Jun 25, 2024.06.25 Request For An Extension-
Jun 20, 2024Fruther Brief Re Preliminary Objection En-
Jun 20, 2024Exhibit Bp74-
Jun 18, 2024He 44 Rc Dusseldorf Order Of 3 May-
Jun 18, 2024He 44A Translation He 44-
Jun 18, 2024He 43 Rc Dusseldorf Order Of 13 May-
Jun 18, 2024He 43A Translation He 43-
Jun 18, 2024240517 Notice Re Preliminary Objection Sgn-
Jun 17, 2024Case Management Preliminary Objection-
May 21, 2024Request To Produce Evidence-
May 21, 2024Receipt-
May 17, 2024Receipt-
May 17, 2024Notice Re Po-
May 17, 2024He 44A-
May 17, 2024He 44-
May 17, 2024He 43A-
May 17, 2024He 43-
May 6, 2024Formal Checks Notification Of Positive Outcome-
May 3, 2024Statement Of Defense And Counterclaim For Revocation Amgen May 3 2024 En Signed-
May 3, 2024Statement Of Defense-
May 3, 2024Exhibit Bp9-
May 3, 2024Exhibit Bp8-
May 3, 2024Exhibit Bp73 Amgen En-
May 3, 2024Exhibit Bp73-
May 3, 2024Exhibit Bp72 Amgen En-
May 3, 2024Exhibit Bp72-
May 3, 2024Exhibit Bp71 Amgen En-
May 3, 2024Exhibit Bp71-
May 3, 2024Exhibit Bp70 Amgen De-
May 3, 2024Exhibit Bp70A Amgen En-
May 3, 2024Exhibit Bp70A-
May 3, 2024Exhibit Bp70-
May 3, 2024Exhibit Bp7-
May 3, 2024Exhibit Bp6 Part 4-
May 3, 2024Exhibit Bp6 Part 3-
May 3, 2024Exhibit Bp6 Part 2-
May 3, 2024Exhibit Bp6 Part 1-
May 3, 2024Exhibit Bp69 Amgen Be-
May 3, 2024Exhibit Bp69A Amgen En-
May 3, 2024Exhibit Bp69A-
May 3, 2024Exhibit Bp69-
May 3, 2024Exhibit Bp68 Amgen It-
May 3, 2024Exhibit Bp68A Amgen En-
May 3, 2024Exhibit Bp68A-
May 3, 2024Exhibit Bp68-
May 3, 2024Exhibit Bp67 Amgen Fr-
May 3, 2024Exhibit Bp67A Amgen En-
May 3, 2024Exhibit Bp67A-
May 3, 2024Exhibit Bp67-
May 3, 2024Exhibit Bp66 Amgen Nl-
May 3, 2024Exhibit Bp66A Amgen En-
May 3, 2024Exhibit Bp66A-
May 3, 2024Exhibit Bp66-
May 3, 2024Exhibit Bp65 Amgen En-
May 3, 2024Exhibit Bp65-
May 3, 2024Exhibit Bp64 Amgen De-
May 3, 2024Exhibit Bp64A Amgen En-
May 3, 2024Exhibit Bp64A-
May 3, 2024Exhibit Bp64-
May 3, 2024Exhibit Bp63 Amgen De-
May 3, 2024Exhibit Bp63A Amgen En-
May 3, 2024Exhibit Bp63A-
May 3, 2024Exhibit Bp63-
May 3, 2024Exhibit Bp62 Amgen De-
May 3, 2024Exhibit Bp62-
May 3, 2024Exhibit Bp61 Amgen En-
May 3, 2024Exhibit Bp61-
May 3, 2024Exhibit Bp60 Amgen De-
May 3, 2024Exhibit Bp60A Amgen En-
May 3, 2024Exhibit Bp60A-
May 3, 2024Exhibit Bp60-
May 3, 2024Exhibit Bp59 Amgen En-
May 3, 2024Exhibit Bp59-
May 3, 2024Exhibit Bp58 Amgen En-
May 3, 2024Exhibit Bp58-
May 3, 2024Exhibit Bp57 Amgen En-
May 3, 2024Exhibit Bp57-
May 3, 2024Exhibit Bp56 Part 2-
May 3, 2024Exhibit Bp56 Part 1-
May 3, 2024Exhibit Bp56 Amgen Part 2 Fr-
May 3, 2024Exhibit Bp56 Amgen Part 1 Fr-
May 3, 2024Exhibit Bp56A Amgen En-
May 3, 2024Exhibit Bp56A-
May 3, 2024Exhibit Bp55 Amgen En-
May 3, 2024Exhibit Bp55-
May 3, 2024Exhibit Bp54 Amgen En-
May 3, 2024Exhibit Bp54-
May 3, 2024Exhibit Bp53 Amgen De-
May 3, 2024Exhibit Bp53A Amgen En-
May 3, 2024Exhibit Bp53A-
May 3, 2024Exhibit Bp53-
May 3, 2024Exhibit Bp52 Amgen De-
May 3, 2024Exhibit Bp52A Amgen En-
May 3, 2024Exhibit Bp52A-
May 3, 2024Exhibit Bp52-
May 3, 2024Exhibit Bp51 Amgen It-
May 3, 2024Exhibit Bp51A Amgen En-
May 3, 2024Exhibit Bp51A-
May 3, 2024Exhibit Bp51-
May 3, 2024Exhibit Bp50 Amgen Fr-
May 3, 2024Exhibit Bp50A Amgen En-
May 3, 2024Exhibit Bp50A-
May 3, 2024Exhibit Bp50-
May 3, 2024Exhibit Bp5-
May 3, 2024Exhibit Bp49 Amgen Fr-
May 3, 2024Exhibit Bp49A Amgen En-
May 3, 2024Exhibit Bp49A-
May 3, 2024Exhibit Bp49-
May 3, 2024Exhibit Bp48 Amgen Fr-
May 3, 2024Exhibit Bp48A Amgen En-
May 3, 2024Exhibit Bp48A-
May 3, 2024Exhibit Bp48-
May 3, 2024Exhibit Bp47 Amgen Nl-
May 3, 2024Exhibit Bp47A Amgen En-
May 3, 2024Exhibit Bp47A-
May 3, 2024Exhibit Bp47-
May 3, 2024Exhibit Bp46 Amgen Nl-
May 3, 2024Exhibit Bp46A Amgen En-
May 3, 2024Exhibit Bp46A-
May 3, 2024Exhibit Bp46-
May 3, 2024Exhibit Bp45 Amgen En-
May 3, 2024Exhibit Bp45-
May 3, 2024Exhibit Bp44 Amgen En-
May 3, 2024Exhibit Bp44-
May 3, 2024Exhibit Bp43 Amgen En-
May 3, 2024Exhibit Bp43-
May 3, 2024Exhibit Bp42 Amgen En-
May 3, 2024Exhibit Bp42-
May 3, 2024Exhibit Bp41 Amgen En-
May 3, 2024Exhibit Bp41-
May 3, 2024Exhibit Bp40 Amgen En-
May 3, 2024Exhibit Bp40-
May 3, 2024Exhibit Bp39 Amgen En-
May 3, 2024Exhibit Bp39-
May 3, 2024Exhibit Bp38 Amgen En-
May 3, 2024Exhibit Bp38-
May 3, 2024Exhibit Bp37 Amgen En-
May 3, 2024Exhibit Bp37-
May 3, 2024Exhibit Bp36 Amgen En-
May 3, 2024Exhibit Bp36-
May 3, 2024Exhibit Bp35 Amgen En-
May 3, 2024Exhibit Bp35-
May 3, 2024Exhibit Bp34 Amgen En-
May 3, 2024Exhibit Bp34A Amgen En-
May 3, 2024Exhibit Bp34A-
May 3, 2024Exhibit Bp34-
May 3, 2024Exhibit Bp33 Amgen De-
May 3, 2024Exhibit Bp33A Amgen En-
May 3, 2024Exhibit Bp33A-
May 3, 2024Exhibit Bp33-
May 3, 2024Exhibit Bp32 Amgen En-
May 3, 2024Exhibit Bp32-
May 3, 2024Exhibit Bp31 Amgen En-
May 3, 2024Exhibit Bp31-
May 3, 2024Exhibit Bp30 Amgen En-
May 3, 2024Exhibit Bp30-
May 3, 2024Exhibit Bp29 Amgen En-
May 3, 2024Exhibit Bp29-
May 3, 2024Exhibit Bp28 Amgen En-
May 3, 2024Exhibit Bp28-
May 3, 2024Exhibit Bp27 Amgen En-
May 3, 2024Exhibit Bp27-
May 3, 2024Exhibit Bp26 Amgen En-
May 3, 2024Exhibit Bp26-
May 3, 2024Exhibit Bp25 Amgen En-
May 3, 2024Exhibit Bp25-
May 3, 2024Exhibit Bp24 Amgen En-
May 3, 2024Exhibit Bp24-
May 3, 2024Exhibit Bp23 Amgen En-
May 3, 2024Exhibit Bp23-
May 3, 2024Exhibit Bp22 Amgen En-
May 3, 2024Exhibit Bp22-
May 3, 2024Exhibit Bp21 Amgen En-
May 3, 2024Exhibit Bp21-
May 3, 2024Exhibit Bp20 Amgen En-
May 3, 2024Exhibit Bp20-
May 3, 2024Exhibit Bp19 Amgen En-
May 3, 2024Exhibit Bp19-
May 3, 2024Exhibit Bp18 Amgen En-
May 3, 2024Exhibit Bp18-
May 3, 2024Exhibit Bp17 Amgen En-
May 3, 2024Exhibit Bp17-
May 3, 2024Exhibit Bp16 Amgen En-
May 3, 2024Exhibit Bp16-
May 3, 2024Exhibit Bp15 Amgen En-
May 3, 2024Exhibit Bp15-
May 3, 2024Exhibit Bp14 Amgen En-
May 3, 2024Exhibit Bp14-
May 3, 2024Exhibit Bp13 Amgen En-
May 3, 2024Exhibit Bp13-
May 3, 2024Exhibit Bp12 Amgen En-
May 3, 2024Exhibit Bp12-
May 3, 2024Exhibit Bp11 Amgen En-
May 3, 2024Exhibit Bp11-
May 3, 2024Exhibit Bp10 Amgen En-
May 3, 2024Exhibit Bp10-
May 3, 2024Exhibit Bp09 Amgen En-
May 3, 2024Exhibit Bp08 Amgen En-
May 3, 2024Exhibit Bp07 Amgen En-
May 3, 2024Exhibit Bp06 Amgen Part 4 En-
May 3, 2024Exhibit Bp06 Amgen Part 3 En-
May 3, 2024Exhibit Bp06 Amgen Part 2 En-
May 3, 2024Exhibit Bp06 Amgen Part 1 En-
May 3, 2024Exhibit Bp05 Amgen En-
May 3, 2024Acknowledgement Of Lodging-
Mar 18, 2024Response To Preliminary Objection-
Mar 18, 2024Federal Patent Court, Summons And Preliminary Opinion In Accordance With Sec. 83 German Patent Act-
Mar 18, 2024Commentpreliminaryobjection-
Mar 4, 2024Preliminary Objection-
Mar 4, 2024Preliminaryobjection-
Mar 4, 2024Exhibit Bp04A-
Mar 4, 2024Exhibit Bp04-
Mar 4, 2024Exhibit Bp03A-
Mar 4, 2024Exhibit Bp03-
Mar 4, 2024Exhibit Bp02A-
Mar 4, 2024Exhibit Bp02-
Mar 4, 2024Exhibit Bp01A-
Mar 4, 2024Exhibit Bp01-
Feb 9, 2024Epouploaddocumentsworkflow-
Feb 9, 2024Document From Epo-
Feb 5, 2024Notification Of Service-
Feb 5, 2024Acknowledgement Of Access To Case-
Jan 25, 2024Receipt-
Jan 25, 2024Panel Appointment-
Jan 25, 2024Formal Checks Notification Of Positive Outcome-
Jan 25, 2024Epo Request For Case Pending-
Jan 10, 2024Proof Of Payment-
Jan 10, 2024He 9 Amgen S Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 8 Claimants Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 7 Board Of Appeal (T1927/22 3.3.04), Minutes Of The Hearing On 6 December-
Jan 10, 2024He 6 Board Of Appeal (T1927/22 3.3.04), Preliminary Opinion On Ep 004 Of 6 October-
Jan 10, 2024He 5 Opposition Division, Grounds For The Decision On Ep 004 Of 16 August-
Jan 10, 2024He 4 Notice On The Outcome Of The Opposition On Ep 004 Of 8/9 June-
Jan 10, 2024He 41 Appointment Alban De La Sabliere-
Jan 10, 2024He 40 Power Of Attorney John C. Conway (French)-
Jan 10, 2024He 40A Translation He 40 (En)-
Jan 10, 2024He 3 EP2756004B1-
Jan 10, 2024He 39 Appointment Larry Coury Secretary Certificate-
Jan 10, 2024He 38 Confirmatory License Agreement-
Jan 10, 2024He 37 Lauer Taxe Excerpt-
Jan 10, 2024He 36 Press Release Of Defendant 1) Of 21. February-
Jan 10, 2024He 35 Press Release Of Defendant 1) Of 21. July-
Jan 10, 2024He 34 EP2215124B9 (Excerpt)-
Jan 10, 2024He 33 Amgen Inc., Annual Report (10 K Filing) For Fiscal Year Ended December 31, (Excerpt)-
Jan 10, 2024He 32 Parhofer Kg Et Al, Drugs Real World Outcomes ; 6: 115 123-
Jan 10, 2024He 31 Ema, Chmp, Chmp DAY 120 List Of Questions, Evolocumab Amgen Europe B.V., Ema/Chmp/33068 (Excerpt)-
Jan 10, 2024He 30 Ema, Chmp, Assessment Report Repatha(R), Ema/Chmp/222019 (Excerpt)-
Jan 10, 2024He 2 Printouts From Patent Register [Bundle]-
Jan 10, 2024He 29 Cmdh Questions & Answers On Usage Patents, Cmdh/279, Rev. 1, May-
Jan 10, 2024He 28 Case T452/14, Laboratoires Ctrs V European Commission, Ecli:Eu:T::373-
Jan 10, 2024He 27 Ema S Guideline On Summary Of Product Characteristics (Smpc) Of September-
Jan 10, 2024He 26 Hoge Raad, Judgement Of 3 November , 15/04934, Ecli:Nl:Hr::2807-
Jan 10, 2024He 26A English Translation (En)-
Jan 10, 2024He 25 Higher Regional Court Of Dusseldorf, Grur , 279 Fulvestrant-
Jan 10, 2024He 25A Machine Translation (En)-
Jan 10, 2024He 24 Fachinformationen Repatha(R)-
Jan 10, 2024He 23 Smpc Of Repatha(R)-
Jan 10, 2024He 22 Website Https://Fachkreise.Amgen.De/Produkte/Repatha/Index-
Jan 10, 2024He 21 Expert Declaration Prof. Klaus G. Parhofer-
Jan 10, 2024He 20 F. Kronenberg Et Al., European Heart Journal () 43, 3925 3946-
Jan 10, 2024He 1 EP3536712B1-
Jan 10, 2024He 19 Wilson Et Al., Journal Of Clinical Lipidology () 13, 374 392-
Jan 10, 2024He 18 V Bermudez Et. Al, American Journal Of Therapeutics 17, 263 273 (2-
Jan 10, 2024He 17 Feature Analysis Patent In Suit-
Jan 10, 2024He 16 Jama. ;302(4):412 423. Doi:10.1001/Jama..1063 (Including Online Supplement)-
Jan 10, 2024He 15 Bennet Et Al, Arch Intern Med, VOL. 168, No. 6, ;-
Jan 10, 2024He 14 Expert Report I By Emanuele Di Angelantonio From The European Opposition Proceedings (D64)-
Jan 10, 2024He 13 Horton Et Al.,-
Jan 10, 2024He 12 Nordestgaard Et Al, European Heart Journal, 31, ,-
Jan 10, 2024He 11 Grounds For Defence To Nullity Action DATED 15 November-
Jan 10, 2024He 10 Amgen S Nullity Action On Ep 004 DATED 3 August Filed Before The Federal Patent Court (3 Ni 21/23)-
Jan 10, 2024Acknowledgement Of Lodging-
Jan 10, 2024240110 Statement Of Claim Sig-
Jun 27, 2025Receipt-
Jun 23, 2025250623 Request Re. Audio Recording-
Jun 16, 2025Workflow Closed
Jun 16, 2025Outcome Of The Order-
Jun 13, 2025Receipt-
Jun 13, 202520250613 Application Cost Decision Amgen-
May 13, 2025Headnote And Keywords-
May 13, 2025Final Decision
May 13, 2025Decisionoutcome-
Apr 30, 2025Outcome Of The Order-
Apr 30, 2025Confirmation Of Appointment
Apr 22, 2025Receipt-
Apr 17, 202520250417 Recording Of Oral Hearing Request Amgen En-
Apr 4, 2025Reschedule Announcement
Mar 3, 2025Request For Correction-
Mar 3, 2025Receipt-
Mar 3, 2025250227 Email Re Correction-
Mar 3, 2025250214 Order Correction Of Claimant'S Name-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S04-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S03-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S02-
Feb 26, 2025597355/Oh/Dus Loc/Upc202502250930Am/S01-
Feb 21, 2025Summon Oral Hearing-
Feb 21, 2025Summary Of Citations-
Feb 21, 2025Response On Requests And Synoptical Table-
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure-
Feb 21, 2025Hearing Dates-
Feb 21, 2025Exhibit Bp 85 Amgen-
Feb 21, 202520250221 Table Of Exhibits And Request Ars Brief Amgen-
Feb 20, 2025Rejecting Time Extension
Feb 20, 2025Rectification Order-
Feb 20, 2025Outcome Of The Order-
Feb 20, 2025Course Of The Oral Hearing
Feb 19, 2025Written Procedure Closure-
Feb 19, 2025Template Order-
Feb 19, 2025Receipt-
Feb 19, 2025Outcome Of The Order-
Feb 19, 2025Order Interim Procedure
Feb 19, 2025Art. 33 3)(A) Upca
Feb 18, 2025Slides For The Hearing On 25 February-
Feb 18, 2025Request On Timing Of Complete Statement Of Claim-
Feb 18, 2025Receipt-
Feb 18, 2025Exhibit Bp84 Amgen-
Feb 18, 2025Cover Letter On Submssion Of Slides-
Feb 18, 202520250218 Response Amgen App 6226 2025-
Feb 18, 202520250218 Comment Re Cfr Amgen App 5925 2025 En Signed-
Feb 14, 2025Outcome Of The Order-
Feb 14, 2025Opportunity To Comment-
Feb 14, 2025Decision Regarding R.9 Request
Feb 14, 2025Correction Name
Feb 6, 2025Receipt-
Feb 5, 2025Receipt-
Feb 5, 2025He 116A-
Feb 5, 2025Application Pursuant To Rule 9.1 Rop-
Feb 5, 20253Rd Prof. Parhofer Declaration-
Feb 4, 2025Sanofi V Amgen Rule 336 Rop Request To File Demonstratives-
Feb 3, 2025Rectification
Jan 30, 2025Separation Of Proceedings
Jan 21, 2025Receipt-
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation-
Jan 20, 2025Receipt-
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action-
Dec 23, 2024R. 20.2 Rop Information
Dec 23, 2024Preliminary Objection Decisionoutcome-
Dec 13, 2024Order Set Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates-
Dec 5, 2024Panel Appointment-
Nov 29, 2024Outcome Of The Order-
Nov 29, 2024Order Inform Pcfi Allocation Tqj
Nov 14, 2024Receipt-
Nov 13, 2024Exhibit Bp83 Court Notice Re Re Scheduled Oral Hearing In Main Damages Case-
Nov 13, 2024Exhibit Bp82 Minutes Oral Hearing In Main Damages Case-
Nov 13, 2024Application To Comment Re. Scheduling Nov 13-
Nov 11, 2024He 115 241016 Munich Court Order-
Nov 11, 2024He 114 Confirmation Ski Rauline (Redacted)-
Nov 11, 2024241111 Comments-
Nov 11, 202420241111 Request For Hearing Date Brief Of Amgen-
Nov 5, 2024Pre Order Opportunity To Comment Oral Hearing Date-
Oct 21, 2024Receipt-
Oct 18, 2024EP857Reply To Amgen Response To Application For Leave To Amend Case (Signed)-
Oct 9, 2024Response To Application For Leave To Amend The Case R263-
Oct 9, 2024Receipt-
Oct 8, 2024241008 Submission On Lis Pendens-
Oct 4, 2024Receipt-
Oct 4, 2024Correction-
Oct 3, 2024Application-
Sep 26, 2024Order Opportunity To Comment-
Sep 25, 2024Receipt-
Sep 25, 2024He 107 Confirmatory License Agreement-
Sep 25, 2024He 105 Intention To Grant-
Sep 25, 2024He 104 Decision To Grant-
Sep 25, 2024Exhibit He 109-
Sep 25, 2024Exhibit He 108-
Sep 25, 2024Exhibit He 106-
Sep 25, 2024Application To Amend Case-
Sep 23, 2024Infringement Rejoinder And Validity Reply-
Sep 23, 2024Exhibit Bp81-
Sep 23, 2024Exhibit Bp80-
Sep 23, 2024Exhibit Bp79-
Sep 23, 2024Exhibit Bp78-
Sep 23, 2024Exhibit Bp77-
Sep 23, 2024Exhibit Bp76-
Sep 23, 2024Exhibit Bp75-
Sep 23, 2024Acknowledgement Of Lodging-
Jul 22, 2024Reply To Defence And Defence To Counterclaim-
Jul 22, 2024He 99 Szarek-
Jul 22, 2024He 98 Safarova-
Jul 22, 2024He 97 Declaration Of Prof Di Angelantonio-
Jul 22, 2024He 96 Swergold Poster-
Jul 22, 2024He 95 Lagor And Millar-
Jul 22, 2024He 94 Excerpt From Clinicaltrials Gov Amg145-
Jul 22, 2024He 93 Excerpt From Clinicaltrials Gov Gauss-
Jul 22, 2024He 92 Declaration Of Prof Parhofer On Validity-
Jul 22, 2024He 91 Nct012884443-
Jul 22, 2024He 90 Repatha Fda Approval-
Jul 22, 2024He 89 Praluent Fda Approval-
Jul 22, 2024He 88 Kamstrup-
Jul 22, 2024He 87 Jama-
Jul 22, 2024He 86 Cohen-
Jul 22, 2024He 85 Romangnuolo-
Jul 22, 2024He 84 Stroes-
Jul 22, 2024He 83 Albers (Aim High)-
Jul 22, 2024He 82 Willeit-
Jul 22, 2024He 81 Sabatine-
Jul 22, 2024He 80 Schwartz-
Jul 22, 2024He 79 Ober-
Jul 22, 2024He 78 Cohen-
Jul 22, 2024He 77 Colhoun-
Jul 22, 2024He 76 Lambert-
Jul 22, 2024He 75 Schmidt-
Jul 22, 2024He 74 Soutar 1991-
Jul 22, 2024He 73 Lamon Fava-
Jul 22, 2024He 72 Anuurad-
Jul 22, 2024He 71 Rader 1995-
Jul 22, 2024He 70 Hobbs 1999-
Jul 22, 2024He 69 Kolski-
Jul 22, 2024He 68 Koschinsky And Boffa-
Jul 22, 2024He 67 Kochinsky And Marcovina-
Jul 22, 2024He 66 Jacobson-
Jul 22, 2024He 65 Dube-
Jul 22, 2024He 64 Clarke-
Jul 22, 2024He 63 Kamstrup-
Jul 22, 2024He 62 Tregouet-
Jul 22, 2024He 61 Davignon-
Jul 22, 2024He 60 Lippi-
Jul 22, 2024He 59 Bonny Eingetreten Im November Sanofi Biotechnology Sas (Fr)-
Jul 22, 2024He 59A En-
Jul 22, 2024He 58 Confirmation Of Power To Act July 16-
Jul 22, 2024He 58A Coury Witness Statement 18 July-
Jul 22, 2024He 57 Laurent Gilhodes As Chairman Of Sanofi Biotechnologies Sas (Fr)-
Jul 22, 2024He 57A En-
Jul 22, 2024He 56 Second Confirmatory License Agreement-
Jul 22, 2024He 55 Poa Executed By Gilhodes (Fr)-
Jul 22, 2024He 55A En-
Jul 22, 2024He 54 Form 8 K Filing To Us Sec April 7-
Jul 22, 2024He 53 2Nd Parhofer Declaration Infringment-
Jul 22, 2024He 52 Smpc Atorvastatin (De)-
Jul 22, 2024He 51 Chmp-
Jul 22, 2024He 51A Report From The Cmdh Meeting Held On 16Th 17Th And 18Th January-
Jul 22, 2024He 50 Statement Of Defence (De)-
Jul 22, 2024He 50A En-
Jul 22, 2024He 49 Smpc Training Presentation Of The Emas Smpc Advisory Group-
Jul 22, 2024He 48 C Ronse-
Jul 22, 2024He 47 Paris 20 Ocober 1913662 (Fr)-
Jul 22, 2024He 47A En-
Jul 22, 2024He 46 O Donoghue Et Al Circulation-
Jul 22, 2024He 46A O Donoghue Et Al Supplemental Material-
Jul 22, 2024He 45 Amgens Reply Of 25 April-
Jul 22, 2024He 45A En-
Jul 22, 2024He 40B Verification Of Electronic Signatures For He 40-
Jul 22, 2024He 38A Verification Of Electronic Signatures For He 38-
Jul 22, 2024He 103 Stein-
Jul 22, 2024He 102 Smpc For Praluent ()-
Jul 22, 2024He 101 Smpc For Repatha ()-
Jul 22, 2024He 100 Summary Of Pre Priority Clinical Trials Using Anti Pcsk9 Antibodies-
Jul 22, 2024Ar 5 Clean-
Jul 22, 2024Ar 5B Amended Description-
Jul 22, 2024Ar 5A Tracked-
Jul 22, 2024Ar 4 Clean-
Jul 22, 2024Ar 4B Amended Description-
Jul 22, 2024Ar 4A Tracked-
Jul 22, 2024Ar 3 Clean-
Jul 22, 2024Ar 3B Amended Description-
Jul 22, 2024Ar 3A Tracked-
Jul 22, 2024Ar 2 Clean-
Jul 22, 2024Ar 2B Amended Description-
Jul 22, 2024Ar 2A Tracked-
Jul 22, 2024Ar 1 Clean-
Jul 22, 2024Ar 1B Amended Description-
Jul 22, 2024Ar 1A Tracked-
Jul 22, 2024Acknowledgement Of Lodging-
Jul 1, 2024Response On Time Extension Request From Sanofi-
Jul 1, 2024Procedural Order Extension Time Limit
Jul 1, 2024Outcome Of The Order-
Jun 26, 2024Receipt-
Jun 26, 2024Opportunity To Comment-
Jun 25, 2024.06.25 Request For An Extension-
Jun 20, 2024Fruther Brief Re Preliminary Objection En-
Jun 20, 2024Exhibit Bp74-
Jun 18, 2024He 44 Rc Dusseldorf Order Of 3 May-
Jun 18, 2024He 44A Translation He 44-
Jun 18, 2024He 43 Rc Dusseldorf Order Of 13 May-
Jun 18, 2024He 43A Translation He 43-
Jun 18, 2024240517 Notice Re Preliminary Objection Sgn-
Jun 17, 2024Case Management Preliminary Objection-
May 21, 2024Request To Produce Evidence-
May 21, 2024Receipt-
May 17, 2024Receipt-
May 17, 2024Notice Re Po-
May 17, 2024He 44A-
May 17, 2024He 44-
May 17, 2024He 43A-
May 17, 2024He 43-
May 6, 2024Formal Checks Notification Of Positive Outcome-
May 3, 2024Statement Of Defense And Counterclaim For Revocation Amgen May 3 2024 En Signed-
May 3, 2024Statement Of Defense-
May 3, 2024Exhibit Bp9-
May 3, 2024Exhibit Bp8-
May 3, 2024Exhibit Bp73 Amgen En-
May 3, 2024Exhibit Bp73-
May 3, 2024Exhibit Bp72 Amgen En-
May 3, 2024Exhibit Bp72-
May 3, 2024Exhibit Bp71 Amgen En-
May 3, 2024Exhibit Bp71-
May 3, 2024Exhibit Bp70 Amgen De-
May 3, 2024Exhibit Bp70A Amgen En-
May 3, 2024Exhibit Bp70A-
May 3, 2024Exhibit Bp70-
May 3, 2024Exhibit Bp7-
May 3, 2024Exhibit Bp6 Part 4-
May 3, 2024Exhibit Bp6 Part 3-
May 3, 2024Exhibit Bp6 Part 2-
May 3, 2024Exhibit Bp6 Part 1-
May 3, 2024Exhibit Bp69 Amgen Be-
May 3, 2024Exhibit Bp69A Amgen En-
May 3, 2024Exhibit Bp69A-
May 3, 2024Exhibit Bp69-
May 3, 2024Exhibit Bp68 Amgen It-
May 3, 2024Exhibit Bp68A Amgen En-
May 3, 2024Exhibit Bp68A-
May 3, 2024Exhibit Bp68-
May 3, 2024Exhibit Bp67 Amgen Fr-
May 3, 2024Exhibit Bp67A Amgen En-
May 3, 2024Exhibit Bp67A-
May 3, 2024Exhibit Bp67-
May 3, 2024Exhibit Bp66 Amgen Nl-
May 3, 2024Exhibit Bp66A Amgen En-
May 3, 2024Exhibit Bp66A-
May 3, 2024Exhibit Bp66-
May 3, 2024Exhibit Bp65 Amgen En-
May 3, 2024Exhibit Bp65-
May 3, 2024Exhibit Bp64 Amgen De-
May 3, 2024Exhibit Bp64A Amgen En-
May 3, 2024Exhibit Bp64A-
May 3, 2024Exhibit Bp64-
May 3, 2024Exhibit Bp63 Amgen De-
May 3, 2024Exhibit Bp63A Amgen En-
May 3, 2024Exhibit Bp63A-
May 3, 2024Exhibit Bp63-
May 3, 2024Exhibit Bp62 Amgen De-
May 3, 2024Exhibit Bp62-
May 3, 2024Exhibit Bp61 Amgen En-
May 3, 2024Exhibit Bp61-
May 3, 2024Exhibit Bp60 Amgen De-
May 3, 2024Exhibit Bp60A Amgen En-
May 3, 2024Exhibit Bp60A-
May 3, 2024Exhibit Bp60-
May 3, 2024Exhibit Bp59 Amgen En-
May 3, 2024Exhibit Bp59-
May 3, 2024Exhibit Bp58 Amgen En-
May 3, 2024Exhibit Bp58-
May 3, 2024Exhibit Bp57 Amgen En-
May 3, 2024Exhibit Bp57-
May 3, 2024Exhibit Bp56 Part 2-
May 3, 2024Exhibit Bp56 Part 1-
May 3, 2024Exhibit Bp56 Amgen Part 2 Fr-
May 3, 2024Exhibit Bp56 Amgen Part 1 Fr-
May 3, 2024Exhibit Bp56A Amgen En-
May 3, 2024Exhibit Bp56A-
May 3, 2024Exhibit Bp55 Amgen En-
May 3, 2024Exhibit Bp55-
May 3, 2024Exhibit Bp54 Amgen En-
May 3, 2024Exhibit Bp54-
May 3, 2024Exhibit Bp53 Amgen De-
May 3, 2024Exhibit Bp53A Amgen En-
May 3, 2024Exhibit Bp53A-
May 3, 2024Exhibit Bp53-
May 3, 2024Exhibit Bp52 Amgen De-
May 3, 2024Exhibit Bp52A Amgen En-
May 3, 2024Exhibit Bp52A-
May 3, 2024Exhibit Bp52-
May 3, 2024Exhibit Bp51 Amgen It-
May 3, 2024Exhibit Bp51A Amgen En-
May 3, 2024Exhibit Bp51A-
May 3, 2024Exhibit Bp51-
May 3, 2024Exhibit Bp50 Amgen Fr-
May 3, 2024Exhibit Bp50A Amgen En-
May 3, 2024Exhibit Bp50A-
May 3, 2024Exhibit Bp50-
May 3, 2024Exhibit Bp5-
May 3, 2024Exhibit Bp49 Amgen Fr-
May 3, 2024Exhibit Bp49A Amgen En-
May 3, 2024Exhibit Bp49A-
May 3, 2024Exhibit Bp49-
May 3, 2024Exhibit Bp48 Amgen Fr-
May 3, 2024Exhibit Bp48A Amgen En-
May 3, 2024Exhibit Bp48A-
May 3, 2024Exhibit Bp48-
May 3, 2024Exhibit Bp47 Amgen Nl-
May 3, 2024Exhibit Bp47A Amgen En-
May 3, 2024Exhibit Bp47A-
May 3, 2024Exhibit Bp47-
May 3, 2024Exhibit Bp46 Amgen Nl-
May 3, 2024Exhibit Bp46A Amgen En-
May 3, 2024Exhibit Bp46A-
May 3, 2024Exhibit Bp46-
May 3, 2024Exhibit Bp45 Amgen En-
May 3, 2024Exhibit Bp45-
May 3, 2024Exhibit Bp44 Amgen En-
May 3, 2024Exhibit Bp44-
May 3, 2024Exhibit Bp43 Amgen En-
May 3, 2024Exhibit Bp43-
May 3, 2024Exhibit Bp42 Amgen En-
May 3, 2024Exhibit Bp42-
May 3, 2024Exhibit Bp41 Amgen En-
May 3, 2024Exhibit Bp41-
May 3, 2024Exhibit Bp40 Amgen En-
May 3, 2024Exhibit Bp40-
May 3, 2024Exhibit Bp39 Amgen En-
May 3, 2024Exhibit Bp39-
May 3, 2024Exhibit Bp38 Amgen En-
May 3, 2024Exhibit Bp38-
May 3, 2024Exhibit Bp37 Amgen En-
May 3, 2024Exhibit Bp37-
May 3, 2024Exhibit Bp36 Amgen En-
May 3, 2024Exhibit Bp36-
May 3, 2024Exhibit Bp35 Amgen En-
May 3, 2024Exhibit Bp35-
May 3, 2024Exhibit Bp34 Amgen En-
May 3, 2024Exhibit Bp34A Amgen En-
May 3, 2024Exhibit Bp34A-
May 3, 2024Exhibit Bp34-
May 3, 2024Exhibit Bp33 Amgen De-
May 3, 2024Exhibit Bp33A Amgen En-
May 3, 2024Exhibit Bp33A-
May 3, 2024Exhibit Bp33-
May 3, 2024Exhibit Bp32 Amgen En-
May 3, 2024Exhibit Bp32-
May 3, 2024Exhibit Bp31 Amgen En-
May 3, 2024Exhibit Bp31-
May 3, 2024Exhibit Bp30 Amgen En-
May 3, 2024Exhibit Bp30-
May 3, 2024Exhibit Bp29 Amgen En-
May 3, 2024Exhibit Bp29-
May 3, 2024Exhibit Bp28 Amgen En-
May 3, 2024Exhibit Bp28-
May 3, 2024Exhibit Bp27 Amgen En-
May 3, 2024Exhibit Bp27-
May 3, 2024Exhibit Bp26 Amgen En-
May 3, 2024Exhibit Bp26-
May 3, 2024Exhibit Bp25 Amgen En-
May 3, 2024Exhibit Bp25-
May 3, 2024Exhibit Bp24 Amgen En-
May 3, 2024Exhibit Bp24-
May 3, 2024Exhibit Bp23 Amgen En-
May 3, 2024Exhibit Bp23-
May 3, 2024Exhibit Bp22 Amgen En-
May 3, 2024Exhibit Bp22-
May 3, 2024Exhibit Bp21 Amgen En-
May 3, 2024Exhibit Bp21-
May 3, 2024Exhibit Bp20 Amgen En-
May 3, 2024Exhibit Bp20-
May 3, 2024Exhibit Bp19 Amgen En-
May 3, 2024Exhibit Bp19-
May 3, 2024Exhibit Bp18 Amgen En-
May 3, 2024Exhibit Bp18-
May 3, 2024Exhibit Bp17 Amgen En-
May 3, 2024Exhibit Bp17-
May 3, 2024Exhibit Bp16 Amgen En-
May 3, 2024Exhibit Bp16-
May 3, 2024Exhibit Bp15 Amgen En-
May 3, 2024Exhibit Bp15-
May 3, 2024Exhibit Bp14 Amgen En-
May 3, 2024Exhibit Bp14-
May 3, 2024Exhibit Bp13 Amgen En-
May 3, 2024Exhibit Bp13-
May 3, 2024Exhibit Bp12 Amgen En-
May 3, 2024Exhibit Bp12-
May 3, 2024Exhibit Bp11 Amgen En-
May 3, 2024Exhibit Bp11-
May 3, 2024Exhibit Bp10 Amgen En-
May 3, 2024Exhibit Bp10-
May 3, 2024Exhibit Bp09 Amgen En-
May 3, 2024Exhibit Bp08 Amgen En-
May 3, 2024Exhibit Bp07 Amgen En-
May 3, 2024Exhibit Bp06 Amgen Part 4 En-
May 3, 2024Exhibit Bp06 Amgen Part 3 En-
May 3, 2024Exhibit Bp06 Amgen Part 2 En-
May 3, 2024Exhibit Bp06 Amgen Part 1 En-
May 3, 2024Exhibit Bp05 Amgen En-
May 3, 2024Acknowledgement Of Lodging-
Mar 18, 2024Response To Preliminary Objection-
Mar 18, 2024Federal Patent Court, Summons And Preliminary Opinion In Accordance With Sec. 83 German Patent Act-
Mar 18, 2024Commentpreliminaryobjection-
Mar 4, 2024Preliminary Objection-
Mar 4, 2024Preliminaryobjection-
Mar 4, 2024Exhibit Bp04A-
Mar 4, 2024Exhibit Bp04-
Mar 4, 2024Exhibit Bp03A-
Mar 4, 2024Exhibit Bp03-
Mar 4, 2024Exhibit Bp02A-
Mar 4, 2024Exhibit Bp02-
Mar 4, 2024Exhibit Bp01A-
Mar 4, 2024Exhibit Bp01-
Feb 9, 2024Epouploaddocumentsworkflow-
Feb 9, 2024Document From Epo-
Feb 5, 2024Notification Of Service-
Feb 5, 2024Acknowledgement Of Access To Case-
Jan 25, 2024Receipt-
Jan 25, 2024Panel Appointment-
Jan 25, 2024Formal Checks Notification Of Positive Outcome-
Jan 25, 2024Epo Request For Case Pending-
Jan 10, 2024Proof Of Payment-
Jan 10, 2024He 9 Amgen S Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 8 Claimants Submissions On Infringement Of Ep 004 Before The Rc Dusseldorf (Bundle)-
Jan 10, 2024He 7 Board Of Appeal (T1927/22 3.3.04), Minutes Of The Hearing On 6 December-
Jan 10, 2024He 6 Board Of Appeal (T1927/22 3.3.04), Preliminary Opinion On Ep 004 Of 6 October-
Jan 10, 2024He 5 Opposition Division, Grounds For The Decision On Ep 004 Of 16 August-
Jan 10, 2024He 4 Notice On The Outcome Of The Opposition On Ep 004 Of 8/9 June-
Jan 10, 2024He 41 Appointment Alban De La Sabliere-
Jan 10, 2024He 40 Power Of Attorney John C. Conway (French)-
Jan 10, 2024He 40A Translation He 40 (En)-
Jan 10, 2024He 3 EP2756004B1-
Jan 10, 2024He 39 Appointment Larry Coury Secretary Certificate-
Jan 10, 2024He 38 Confirmatory License Agreement-
Jan 10, 2024He 37 Lauer Taxe Excerpt-
Jan 10, 2024He 36 Press Release Of Defendant 1) Of 21. February-
Jan 10, 2024He 35 Press Release Of Defendant 1) Of 21. July-
Jan 10, 2024He 34 EP2215124B9 (Excerpt)-
Jan 10, 2024He 33 Amgen Inc., Annual Report (10 K Filing) For Fiscal Year Ended December 31, (Excerpt)-
Jan 10, 2024He 32 Parhofer Kg Et Al, Drugs Real World Outcomes ; 6: 115 123-
Jan 10, 2024He 31 Ema, Chmp, Chmp DAY 120 List Of Questions, Evolocumab Amgen Europe B.V., Ema/Chmp/33068 (Excerpt)-
Jan 10, 2024He 30 Ema, Chmp, Assessment Report Repatha(R), Ema/Chmp/222019 (Excerpt)-
Jan 10, 2024He 2 Printouts From Patent Register [Bundle]-
Jan 10, 2024He 29 Cmdh Questions & Answers On Usage Patents, Cmdh/279, Rev. 1, May-
Jan 10, 2024He 28 Case T452/14, Laboratoires Ctrs V European Commission, Ecli:Eu:T::373-
Jan 10, 2024He 27 Ema S Guideline On Summary Of Product Characteristics (Smpc) Of September-
Jan 10, 2024He 26 Hoge Raad, Judgement Of 3 November , 15/04934, Ecli:Nl:Hr::2807-
Jan 10, 2024He 26A English Translation (En)-
Jan 10, 2024He 25 Higher Regional Court Of Dusseldorf, Grur , 279 Fulvestrant-
Jan 10, 2024He 25A Machine Translation (En)-
Jan 10, 2024He 24 Fachinformationen Repatha(R)-
Jan 10, 2024He 23 Smpc Of Repatha(R)-
Jan 10, 2024He 22 Website Https://Fachkreise.Amgen.De/Produkte/Repatha/Index-
Jan 10, 2024He 21 Expert Declaration Prof. Klaus G. Parhofer-
Jan 10, 2024He 20 F. Kronenberg Et Al., European Heart Journal () 43, 3925 3946-
Jan 10, 2024He 1 EP3536712B1-
Jan 10, 2024He 19 Wilson Et Al., Journal Of Clinical Lipidology () 13, 374 392-
Jan 10, 2024He 18 V Bermudez Et. Al, American Journal Of Therapeutics 17, 263 273 (2-
Jan 10, 2024He 17 Feature Analysis Patent In Suit-
Jan 10, 2024He 16 Jama. ;302(4):412 423. Doi:10.1001/Jama..1063 (Including Online Supplement)-
Jan 10, 2024He 15 Bennet Et Al, Arch Intern Med, VOL. 168, No. 6, ;-
Jan 10, 2024He 14 Expert Report I By Emanuele Di Angelantonio From The European Opposition Proceedings (D64)-
Jan 10, 2024He 13 Horton Et Al.,-
Jan 10, 2024He 12 Nordestgaard Et Al, European Heart Journal, 31, ,-
Jan 10, 2024He 11 Grounds For Defence To Nullity Action DATED 15 November-
Jan 10, 2024He 10 Amgen S Nullity Action On Ep 004 DATED 3 August Filed Before The Federal Patent Court (3 Ni 21/23)-
Jan 10, 2024Acknowledgement Of Lodging-
Jan 10, 2024240110 Statement Of Claim Sig-

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen Europe
UPC_COA_641/2025Jul 14, 2025Sanofi BiotechnologyAmgen
APL_32765/2025Jul 11, 2025Amgen, Amgen EuropeRegeneron Pharmaceuticals

More cases involving Sanofi Biotechnologies

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Sanofi BiotechnologiesAmgen, Amgen Europe
App_29861/2025Jun 27, 2025Sanofi Biotechnologies -
ORD_16586/2025Apr 4, 2025Sanofi BiotechnologiesAmgen, Amgen Europe

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -